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ABSTRACT
PURIFICATION AND CHARACTERIZATION OF AN INHIBITOR OF 
THYMIDINE UPTAKE FROM CULTURE SUPERNATANTS OF 
HUMAN TONSIL LYMPHOCYTES 
by
Abdolreza Zarnegar
Lymphocytes from human tonsils were cultured in the absence of 
serum for 3 days. In the presence of the concentrated culture 
supernatant the proliferative response of PBL to con A, as measured by 
the uptake of H-tdr, was significantly reduced. The suppressor 
substance was referred to as SMAL (suppressor of mitogen activated 
lymphocytes). The estimated molecular weight of SMAL under 
nondenaturing conditions was 100,000-300,000. SMAL also suppressed the 
Incorporation of H-tdr by a variety of mouse and human tumor cell 
lines. The activity of SMAL was sensitive to pronase and heating at ' 
100°C for 30 minutes but insensitive to RNase. Treatment with DNase, 
however, enhanced the activity of SMAL. SMAL activity was also 
destroyed by treatment with 5% TCA, 0.4 M HC1 or 60% acetonltrlle, but 
resistant to 6 M urea or dialysis against pH 2 buffer for 24 hours.
SMAL activity was precipitated in 40-80% ammonium sulfate saturation. 
When applied to a phenyl-sepharose column no activity was recovered.
SMAL was not produced by heat-killed tonsil lymphocytes or 
lymphocytes-treated with cydoheximide. Maximal production occurred in 
the first 24 hours of culture, and progressively less was produced in 
subsequent 24-hour Intervals. Both T- and B lymphocyte-enriched culture 
supernatants contained SMAL. SMAL adhered strongly to DEAE-celulose, 
but less than two-fold purification was achieved. Using QMA-Accell 
anion exchange medium, a 5-fold purification of SMAL with higher 
specific activity was obtained with HPLC. Activity of SMAL was 
recovered after native polyacrylamide gel electrophoresis by 
electroblotting to DEAE-cellulose paper followed by eluting the bound 
materials with salt. Two active components, one corresponding to a 
large and/or less negatively charged molecule and another corresponding 
to a small and/or highly acidic molecule, were recovered.
HPLC-purlfled SMAL at relatively low doses inhibited the uptake and 
phosphorylation of H-tdr, without-slgnifleant effect on cell 
proliferation. The inhibition of H-tdr uptake was favored over that of 
H-udr or H-adr, and this effect was reversible. At relatively high 
doses of HPLC-purlfled SMAL, the growth of mouse thymoma EL-4 and human 
T cell leukemia CEM-CM^ cell lines was inhibited.
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OBJECTIVES
The detailed biological and biochemical analysis of regulatory 
factors (lymphokines) has been precluded by the Isolation of only small 
quantity of biological active materials. Many assay systems used for 
the demonstration of activating or Inhibitory properties have been 
carried out using non-selected cell populations. This has complicated 
the detailed analysis of the target cells and the mode of action of 
factors.
It was shown previously (Hodge and Inman, 1982) that culture fluids
3
from human tonsil lymphocytes inhibited the incorporation of H-tdr by 
con A-actlvated human peripheral blood lymphocytes (PBL). This standard 
proliferation assay (con A stimulation of PBL) had several 
disadvantages. These included heterogeneity of the target cells, 
variation in response to con A among lymphocytes of different blood 
donors, and long period that was required to activate PBL. Therefore, 
one objective of this work was to develop a more sensitive and reliable 
assay for the suppressive-active substance in the culture supernatants. 
Once such an assay was developed it would facilitate investigation of 
some of the biological and biochemical properties of the suppressor 
factor.
Another problem with the previous study was that the culture 
supernatant used were heterogenous and contained many different 
proteins, and it was unclear which component was responsible for the 
suppressor activity. The next objective was to purify further the 
suppressor factor and demonstrate that the purified materlal(s) could 
also exhibit the same activity as that of the crude preparations. The
mechanism of action of the suppressor factor on human PBL also was not 
clear. One reason was that the target cells (PBL) consisted of a 
mixture of mononuclear cells namely T and B lymphocytes, and macrophages 
each of which are capable of producing helper and/or suppressor factors. 
This in turn could make the analysis of the mode of action of the 
suppressor factor difficult. The final objective was to investigate the 
modes by which the suppressor factor exerted its effects.
vi
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CHAPTER 1 
IntroduceIon
The immune response is the result o£ a complex network o£ 
interactions among different lymphocytes and accessory cells and is 
largely mediated or regulated by the effect of soluble factors 
(lymphokines and cytokines) (Adorini, 1982) on various cells. The word 
lymphoklne was first proposed by Dumonde et al. (1969) and is synonymous 
with the following terms: lymphocyte mediator, soluble lymphocyte 
mediator, lymphocyte activation product, soluble lymphocyte product, 
mediator of cellular Immunity. Lymphokines are defined by a number of
characteristics that are briefly discussed below. They are soluble
( *
substances produced by lymphoid cells cultured in vitro for relatively 
brief intervals. Lymphokines are not immunoglobulins and do not possess 
structural similarity to any known immunoglobulin molecules. They are 
generally not preformed cellular components and are, therefore, not 
present, in substantial amounts, in resting lymphocytes. Most 
lymphokines are glycoproteins of a M.W. larger than 10,000. Each 
lymphoklne was discovered, defined, and assayed by a specific biological 
activity on a target cell, in most cases under in vitro conditions. A 
number of lymphokines appear to affect their target cells by reacting 
with specific membrane receptors, although such receptors have not been 
demonstrated for most lymphokines. For the most part, lymphokines do 
not appear to be enzymes. They affect a wide variety of cells including 
lymphocytes, macrophages, neutrophils, basophils, eosinophils, 
polymorphonuclear leukocytes, thymocytes, and bone marrow
cells, fibroblasts, lymphoid cell lines, osteoclasts and endothelial 
cells. There Is hardly any area of the Immune response in which 
lymphoklne action has not been, demonstrated or Inferred, Including (1) 
attraction and trapping of circulating inflammatory cells; (2) 
regulation of lymphocyte traffic through lymphoid organs; (3) regulation 
of vascular permeability; (4) promotion of cell division and Induction 
of cell maturation for a variety of cells, including T and B 
lymphocytes, macrophages and hematopoietic stem cells; (5) Inhibition of 
cell proliferation and cytotoxicity for a variety of animal cells as 
well as bacteria and yeasts; and (6) cooperation between T- and 
B-lymphocytes or between macrophages and lymphocytes during the 
development of an immune response.
In attempting to define more precisely the biological role of a 
lymphoklne and to characterize and isolate such a substance, one is 
repeatedly stumbling over a number of difficulties, which held the whole 
field in disrepute for a number of years. These are: (a) the fact that 
lymphokines are usually produced by a mixture of cell types and may 
often require cooperation (e.g. among lymphocytes and macrophages) in 
order to be effectively produced; (b) that, correspondingly, any culture 
supernatant from activated cells usually contains several different 
lymphokines; and (c) that the target cell populations used for assessing 
lymphoklne biological activity are themselves frequently heterogenous 
and capable of producing lymphokines having an enhancing or inhibiting 
effect on the biological assay under study. Although more than 90 
lymphoklne activities have been described (Waksman, 1979) only a few of
them have been characterized as to their chemical structures, biologic 
activities, metabolic regulation, and functional mechanisms.
In most cases, the limitation is due to the unavailability of 
substantial quantities of particular lymphokines. Recently, by using 
improved methods of lymphoklne production and purification it has been 
shown that the biological activity of some lymphokines can be attributed 
to single molecular entities which act on defined cell populations 
(Gillis and Inman, 198S).
A comprehensive review of all the lymphokines is beyond the scope 
of this dissertation; Instead the reader is referred to other sources 
for further discussion of this extensive topic (Cohen et al., 1979; 
Hadden and Stewart, 1981; Flck, 1981; Altman and Katz, 1980; Taussig, 
1980; Gillis and Inman, 1985; Lachman and Malzel, 1983). The present 
review will describe one of the best characterized lymphokines (IL-2), 
which is the prototype of helper factors.
Horgan et al. in 1976 observed that addition of tissue culture 
medium conditioned by mitogen-stimulated human peripheral blood 
lymphocytes to human leukemic blood or bone marrow cells resulted in the 
in vitro proliferation of these cells. Surface phenotype and functional 
data confirmed that the cells replicating in the presence of such 
conditioned media were normal T lymphocytes (Ruscetti et al., 1977). 
Gillis and Smith (1977) were then successful in developing methods which 
have allowed for the indefinite in vitro proliferation of murine 
cytotoxic T lymphocytes. Growth of these effector T-cell populations 
was dependent on the presence of murine or rat spleen cell conditioned 
medium. Subsequent experiments led to the development of similar
methods for the long-term culture of human cytotoKic T cell lines 
(Gillis et al.* 1978), as well as adaptation of protocols for In vitro 
maintenance of cloned cytotoxic and helper T-cell populations (Gillis et 
al.t 1979; Watson, 1979; Schreler et al., 1980). Purified XL-2 has been 
shown to trigger the proliferative expansion of activated T cell clones, 
enhance thymocyte mltogenesls, and Induce alloantigen specific 
thymocytes and nude spleen cytolytic T cell reactivity (Watson et al., 
1979; Gillis et al., 1980; Gillis and Watson, 1980).
The biological and biochemical characterization of this lymphoklne 
has been enhanced because of a reliable and reproducible bloassay. The 
assay system Is based on the original observation of Gillis and Smith 
(1977) that cytotoxic T lymphocyte lines (CTLL) depend upon the presence 
of IL-2 for proliferation. Because murine CTLL cells proliferate In 
response to IL-2 activity present In medium conditioned by mouse, rat, 
or human lymphocytes, IL-2 microassay have been Invaluable In purifying 
and characterizing the IL-2 from all three species.
Production of large quantities of IL-2 by a human T-leukemia cell 
line, named Jurkat (Gillis and Watson, 1980), provided the first key to 
the purification and elucidation of the factor's structure. The second 
breakthrough was the cloning of a cDNA corresponding to IL-2 mRNA by 
Tanlguchl et al. (1983) and Shuichiro et al. (1983) and production of 
recombinant IL-2 by Rosenberg and Grimm (1984). Wang et al. (1984) were 
able to mutagenlze specifically the IL-2 gene by site directed 
mutagenesis and obtain useful data concerning the structure and function 
of IL-2. Nucleotide sequence analysis of the IL-2 gene revealed that 
the encoded IL-2 protein had three cysteines located at amino acid
residue 58, 105, and 125 o£ the mature protein. Since substitution of 
these cystelneB by serine via site specific mutagenesis at either 
position 58 or 105 of the IL-2 protein substantially reduced the 
biological activity, the authors concluded that the cysteines at these 
positions were necessary for maintenance of the biologically active 
conformation and may, therefore, be linked by a disulfide bridge. The 
modified IL-2 protein containing a substitution at position 125 retained 
its full biological activity suggesting that the cysteine at thia 
position was not Involved in a disulfide bridge and that a free 
sulfhydryl group at that position was not necessary for receptor 
binding. Selgel et al. (1984) were able to localize the IL-2 gene on 
human chromosomes. Using a molecular clone of human IL-2 and DNA 
extracted from a panel of somatic cell hybrids the IL-2 structural gene 
was Identified on human chromosome 4.
Recently, the IL-2 receptor was Identified and characterized using 
monoclonal antibody against the receptor protein. Also three groups 
succeeded in cloning cDNA's for the human IL-2 receptor protein (for 
review see Waldmann, 1986). These findings provide a basis for further 
investigations of the biology, chemistry and molecular genetics of other 
lymphokines.
A rather large number of lymphokines have also been implicated as 
suppressors of cellular proliferation and DNA synthesis of 
immunocompetent cells. Larsson and Blomgren (1978) demonstrated the 
existence of a factor produced by PHA-stimulated PBL which induced 
macrophages to become suppressive to antigen-stimulated PBL. Green et 
al. (1970) isolated a suppressor factor from PHA-stimulated human PBL
that inhibited the growth of a variety of transformed cell lines. 
Williams et al. (1978) described a factor produced by con A-atlmulated X 
cell-enriched lymphocytes that could suppress the mixed lymphocyte 
culture response without loss of viability. The activity was sensitive 
to chymotrypsln treatment, non-dialyzable, partially labile at 56“C for 
30 min, and sensitive to pH 2 after 24 hr. Shou et al. (1980) showed 
that supernatants from unstimulated normal human PBL contained factor(s) 
that Inhibited the con A-activation of human PBL. Greene et al. (1961) 
Identified two soluble immune suppressor substances (SISS) in FHA or con 
A-stlmulated human PBL culture supernatants. SISS-T was shown to 
inhibit the proliferative response of T cells to mitogens and antigens. 
This factor had an apparent M.W. of 30,000-40,000. The other factor 
SISS-B inhibited polyclonal B cell activation and had a H.W. of 80,000. 
Both factors were sensitive to heat (56°C for 30 min). Another soluble 
suppressor factor (SSF) produced by Pokweed mitogen-stimulated PBL was 
found by Hoffman et al. (1980). It inhibited MLC and the generation of 
killer cells.
An Inhibitor of DNA synthesis (IDS) was suggested by Jegasothy et 
al. (1981). IDS was produced by con A-stlmulated human PBL and was 
glycoprotein in nature. The presence of the carbohydrate moiety was 
shown to be necessary for its biological activity. The M.W. of the 
monomer IDS wsb estimated to be 20,000 but it was usually found as 
dimers, trimers, and tetramers in solution. It was sensitive to trypsin 
and periodate but stable to heat (60°C for 30 min) and was not 
cytotoxic for target cells.
Cell extracts from lysed PBL were shown by Tibbetts et al. (1975) 
to contain a suppressor factor which Inhibited both the PRA-stlmulation 
of PBL, and the growth of a transformed B cell line. The suppressor was 
trypsin sensitive, stable to both treatment with DNase or exposure to pH 
values between 5.4-8,5, and had an apparent M.W. of greater than 
100,000. Wolf et al, (1978) demonstrated that a subpopulation of T 
lymphocytes also produced a suppressor factor that Inhibited the 
activation of human PBL by con A. The factor had an apparent M.W. 
greater than 100,000 and was stable to heating at 60°C for 15 min.
Culture supernatants from transformed cell lines have also been 
used as a source of soluble suppressor factors. Vesole et al. (1979) 
Identified a soluble inhibitor of PHA-stlmulated lymphocytes from either 
human T or B cell lines. The suppressor activity co-eluted from a 
sephadex G-100 with albumin. Green et al. (1974) Isolated a suppressor 
of mitogen-stimulated PBL from crowded lymphoblastoid culture 
supernatant fluids. The factor was nondlalyzable and had an apparent 
M.W. of 40,000 to 70,000. The suppressor activity was heat stable at 
56°C for 30 min but was destroyed at 80°C for 30 min. It was also 
sensitive to pronase and to pH below 2.4.
Another suppressor factor named stimulated rat T-cell derived 
Inhibitory factor (STIF) was isolated from the culture supernatant of 
con A-stlmulated rat spleen cells (Chiba et al., 1985a). STIF could 
inhibit the DNA synthesis of mouse bone marrow cells as well as a 
variety of normal and neoplaBtic cells from the mouse, rat, and human. 
STIF was a protein with an apparent M.W. of 45,000-50,000 as estimated
by gel filtration. It apparently could Inhibit the production of T cell 
growth factor (IL-2) as well as proliferation of IL-2-dependent T cells 
(Chiba et all, 1985b).
Kramer et al. (1982) isolated a 10,000 M.W. suppressor factor (SF) 
from culture supernatant of alloantigen-activated mouse spleen cells.
SF was shown to inhibit the proliferative response of X cells to 
alloantlgen and the release of IL-2 from producer T cells.
Suppressor cell Induction factor (SIF) was Isolated from MLC 
culture supernatant by Kasakura et al. (1983) which had the ability to 
Induce suppressor function In human T cells. These T cells In turn 
could inhibit the proliferation of the responder cells in MLC. SIF had 
a M.W. of 18,000 to 29,000 as estimated by gel filtration column 
chromatography and did not bind to DEAE-cellulose (Kasakura et al., 
1983).
Proliferation Inhibitor Factor (PIF) reportedly was produced by 
unstimulated or by mitogen-activated leukocytes (Badger et al., 1971). 
This factor was trypsin sensitive, heat stable at 85°C for 30 min, and 
nondializable. PIF and lymphotoxln subsequently were shown to be very 
similar or Identical molecules (Jeffes and Granger, 1975).
Another soluble suppressor factor, named soluble suppressor of 
immune response (SIRS), was isolated from mouse T cells activated with 
con A or interferon (Rich and Fierce, 1974; Aune and Pierce, 1982; 
Schnaper et al., 1984). It inhibited cell division in a variety of 
normal and transformed cell lines and blocked antibody production by B 
cellB in vitro. SIRS was stable at 56°C for 60 min, but was destroyed 
within 10 min at 70°C and by dialysis against pH 2 buffer. SIRS
activity was resistant to DNase and RNase, but sensitive to trypsin, 
chymotrypain, and neuraminidase. Studies by Aune and Fierce (1981a,b) 
established that SIRS must be activated by HjOj to exert its biological 
effects. SIRS action was blocked by sulfhydryl reagents, catalase, and 
ascorbic acid. It appeared that SIRS mediated inhibition of cell 
division by causing oxidation of sulfhydryl groups of cellular proteins. 
It was demonstrated that SIRS could disrupt the normal array of 
intracellular microtubules as well as inhibition of tublln 
polymerization in a cell free system. SIRS was purified by reverse 
phase HPLC and was found to have a M.W. of 14,000-21,000. mRNA for SIRS 
was also isolated and characterized by Nowowiejski-Wieder et al. (1984) 
using a cell free translation system. RNA coding SIRS activity was 
recovered in two fractions: one corresponded to a 25S fragment, the
other was a 21S fragment. Further analysis of SIRS showed that it 
existed in three different isoforma as revealed by differential elution 
from reverse phase HPLC or by isoelectrofocusing (Webb et al., 1985).
Recently Schnaper and Aune, (1986) demonstrated that purified SIRS 
could also suppress the Immune response of mice to sheep erythrocytes in 
vivo.
Medoff et al. (1986) Isolated a suppressor factor from ascites 
fluid of cancer patients. The factor could reduce the incorporation of
3
H-tdr by con A-stimulated normal human PBL. The suppressor was 
precipitated at 0 to 25% ammonium sulfate saturation. Sephadex G-200 
revealed that aggregation of the factor occurred in isotonic buffer, 
however, aggregation was reduced in the presence of 8 M urea. 
Purification of this factor was achieved by precipitation with 5% TCA.
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The suppressor factor remained soluble In TCA and demonstrated a 952 
increase In the specific activity. The suppressor activity was stable 
to heat (70QC for 30 min)* pH 2 and pH 10 for 24 hr. Delipidatlon by 
chloroform-methanol extraction* or proteolytic enzyme digestion did not 
affect the suppressor activity. However* periodate oxidation 
Irreversibly destroyed suppressor activity which suggested the 
importance of a carbohydrate moiety present in the suppressor molecule.
It was shown by Rabin et al. (1986) that gamma Interferon could 
inhibit the activation of resting B-cells by B-cell stimulatory factor 
(BSF). Interferon blocked both the volume enlargement and preparation 
for DNA synthesis caused by B-cell stimulatory factor, although it had 
little effect on B cells already stimulated by BSF. This suggested a 
mutual regulatory Interaction between the interferon and BSF both of 
which are T cell derived products.
Sayers et al. (1986) demonstrated that supernatants from the 
coculture of human PBL and the natural killer cell-susceptible cell line 
KS62 were cytostatic against a variety of tumor cell lines. This factor 
was different from other known factors such as Interferon* lymphotoxin 
or tumor necrosis factor. The physicochemical properties of this factor 
has not been reported yet.
Fujiwara et al. (1987) reported that U937 cells* a human 
macrophage-like cell line* spontaneously produced a factor which 
inhibited blastogenic responses of human blood T lymphocytes stimulated 
with PHA or tuberculin-purified protein derivative (PPD). This 
suppressor factor was precipitable by 33 to 67% saturated ammonium 
sulfate and was Inactivated at pH 2 or pH 11. The apparent M.W. of the
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suppressor was between 67,000 and 130,000 as was estimated by Sephacryl 
S-200 gel filtration chromatogrpahy. The U937 suppressor factor 
Inhibited the production of IL-2 by normal as well as the leukemic human 
T cell line, Jurkat, when were stimulated with PHA. It inferfered also 
with the expression of IL-2 receptor on stimulated blood T lymphocytes. 
However, this factor did not inhibit spontaneous proliferation of the 
human leukemic T cell lines Jurkat or CCRF-CEM at low doses.
In recent years, much interest also has been centered on proteins 
isolated from activated leukocytes that possess cytotoxic or cytostatic 
activities against tumor cells In vivo and In vitro. For example, 
interferons (IFN) have been reported to have growth inhibitory activity 
against a variety of cell lines in vitro (Gresser and Tovey, 1978; Rubin 
and Gupta, 1980; Tyring et al., 1982; Blalock et al., 1980). Another 
anticellular agent is lymphotoxin (LT) which was initially derived from 
culture supernatants of antigen or mitogen-activated lymphocytes 
(Granger et al., 1969; Hlserodt et al., 1976). Lymphotoxin was reported 
to have tumoricldal activity against a range of tumor cells in vitro and 
antlcarcinogenic activity against cells undergoing neoplastic 
transformation (Rosenberg et al., 1973; Sawada et al., 1976; Ransom et 
al., 1983). In 1975, Carswell et al. described a molecule with 
properties similar to LT which they called tumor necrosis factor (INF). 
In common with LT, TNF displayed cytostatic and/or cytocldal activity 
against several tranformed cell lines ij* vitro, but normal cells were 
unaffected by its action (Carswell et al., 1975; Mathews and Watkins, 
1978; Helson et al., 1975).
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Because only very small amounts of LT or TNF were available, little 
was known of their biochemical properties. Indeed, a variety of M.W. 
had been reported probably due to differing molecular forms of the 
molecules. Recently, however, Aggarwal et al. (1985a,b), have succeeded 
in purifying monomeric LT and TNF to homogeneity. LT obtained from a 
lymphoblastold cell line and had a M.W. of 18,644, whereas, TNF prepared 
from a promyelocytic leukemia cell line had an apparent M.W. of 17,000. 
Although strong similarities in amino acid composition were noted, 
antibodies were developed to each molecule which could distinguish 
between the two. Successful cloning of LT and TNF genes into E. coll 
has further demonstrated strong similarities in amino acid composition 
between the two (about 30Z amino acid sequence homology) (Gray et al., 
1984; Fennlca et al., 1984).
As documented by the preceding literature review, there are large 
numbers of suppressor proteins produced by lymphocytes which also affect 
lymphocyte proliferation. The precise molecular mechanism by which 
these factors inhibit cell proliferation is not completely known. 
Therefore an in depth understanding of the modes of action of growth 
inhibitors may help to answer some of the many questions regarding the 
control of cell proliferation, which is a fundamental problem in 
biological science.
Hodge and Inman (1982) reported that culture supernatants of human 
tonsilar lymphocytes contained a high M.W. suppressor factor that could 
suppress the proliferative response of PBL to con A as measured by the
3
reduced incorporation of H-tdr. The use of PBL as target cells was, 
however, lengthy and inconvenient. This made the assay less
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attractive for monitoring further purification and characterization of 
the suppressor factor. The objectives of the present work were to 
purify the suppressive protein produced by TL and to determine how It 
suppresses the proliferation of target EL-4 cells. In this paper, the 
progress toward purification and characterization of the suppressor 
protein is reported.
CHAPTER 2 
Material and Methods
Preparation of Tonsil Lymphocyte Culture Supernatants. Palatine 
tonsils from patientB undergoing elective surgery for recurrent 
tonsilitls were placed immediately in ice-cold transport medium 
consisting of RPMI-1640 supplemented with penicillin (100 U/ml), 
streptomycin (100 pg/ml), HEPES (25 tnM), and Funglsone (2 pg/ml) for 
transport from the hospital to the laboratory. Tonsil lymphocytes (TL) 
were obtained essentially as described by Hodge and Inman (1982) and 
adjusted to the desired cell density (1-12 x 10®/ml) in TL culture 
medium (RPMI-1640 supplemented as above but without Funglsone). These 
primary cultures were incubated In tissue culture flasks for 1-3 days In 
95% air-5% CO,, at 37°C.
The cultures were terminated by centrifugation at 400 x g for 10 
min, and the supernatants to be assayed on human PBL were lyophilized. 
The powder then was dissolved in a volume (typically 30-50 ml) of 
deionized water and centrifuged for 1 hr at 100,000 x g. The 
supernatant was dlalyzed In 0.05 M NH^HCO^ solution adjusted to pH 7.2 
with 1 M HC1, and lyophilized. The powder was stored at -70®C or 
rehydrated and used immediately. When EL-4 cells were used as targets 
the culture supernatants were concentrated 40-fold by Diaflo 
ultrafiltration at 4°C with nitrogen using XM-100 or YM-100 membranes. 
The membranes had a retention selectivity of 100,000. The retentates 
were washed 3 times by diluting them 30-fold with culture medium and
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concentrating them again. The washed retentates were centrifuged at
100,000 x g for 30 min at 5°C. They were used soon or were stored at 
-70°C.
Tumor Cells. All cultures were routinely maintained at 37°C in a 
humidified atmosphere of 51 CO^ in RPMI-1640 medium supplemented with 
25 mM HEPES, penicillin, streptomycin, and 10Z FBS. The following cell 
lines were used: EL-4 (a mouse thymoma cell line), P388D (a mouse 
macrophage cell line), CEM-CMj (a human T cell leukemia), MRC (a human 
embryonic lung fibroblast cell line), HEP-2 (a human epithelial 
carcinoma cell line), and MDCK (a dog epithelial cell line). Cells were 
maintained by transferring them to fresh medium every 3 to 4 days. This 
resulted In a starting cell density of about 2 x 10^ cells per ml.
3
Assay for Suppression of H-tdr Uptake by Activated PBL. The 
lyophilized TL culture supernatant was dissolved in phosphate-buffered 
saline (PBS; 0.15 M NaCl, 0.0076 M l^HPO^, 0.0024 M KHjPO^, adjusted to 
pH 7.4 with 1 M NaOH), and dialyzed in PBL medium [TL culture medium 
plus gentamycin sulfate (50 ug/ml)]. The assay on con A-actlvated PBL 
was done as described previously by Hodge and Inman (1982). In brief, 
0.1 ml PBL (4 x 10^ cells/ml) was pipetted into each well of the Costar 
Tissue Culture Cluster followed by 0.1 ml of the reconstituted TL 
culture supernatant, usually at a 40-fold concentration. 0.025 ml of 
100 pg/ml stock solution of con A was added, and the cultures were 
Incubated for 72 hr. Controls included the response of the PBL to con A 
In the absence of TL culture supernatant as well as PBL Incubated only
3
in PBL medium with serum. To each well was added 1 jiCi of H-tdr and 
Incubation was continued another 14 hr. The cells were then harvested
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on GF/C filter papers using a MASH-II multiple harvester 
(Microbiological Associates)* The filters were dried and placed in 
plastic mini-vials containing 4 ml Scintlsol (Isolab), and radioactivity 
was determined in a Beckman 3155T Scintillation Counter. Suppression 
was calculated by the the formula:
cpm experimental 
X Suppression “ (1 - — — — — ^ —  ) X 100
cpm con A-stlmulated control
Molecular Sieve Chromatography. Concentrated TL culture 
supernatants were filtered through a column (1.6 cm x 90 cm) of 
Fractogel TSK-HW 55S equilibrated with 0.05 M Trie HC1, 0.5 M NaCl 
buffer, pH 8. The column was eluted at about 19 ml/hr and 2-ml 
fractions from the column were collected. Calibration proteins Included 
ferritin (440,000 d.), catalase (232,000 d.), aldolase (158,000 d.), and 
myoglobin (17,000 d.). Fractions were pooled to encompass peaks and 
other regions detected at wavelength of 280 tun. The pools were 
concentrated on a YM-10 ultrafilter (Amicon) to an appropriate volume 
which was loaded originally on the column, washed with 0,05 M Tris, pH 
8, dialyzed in PBS and then in PBL medium. The pools were filter- 
sterilized (0.22 micron) and assayed using EL-4 cells as targets (see 
below).
Ultrafiltration of TL Culture Supernatants. TL culture 
supernatants were filtered through various Amicon ultrafilters using 
for pressurizatlon. The ultraflltcrs Included XM-300, XM-100 or YM-100, 
XM-50, YM-10 and YM-2. The retentates were washed with RPMI-1640 three 
times and filter-sterilized prior to assay for SMAL. Retentates of
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various samples not used for assay were washed with a buffer appropriate 
for their intended use.
Analytical Gel Electrophoresis. Electrophoresis of 30-100 pg of 
20 mM mercaptoethanol-reduced and 0.1% SDS-denatured protein samples was 
done in 10% polyacrylamide gels 1.5 mm thick as described by Laemmli 
(1970) using a Bio-Rad Mini-vertical Model 360 slab gel electrophoresis 
apparatus (B cm x 8 cm). An LKB 2103 power supplier provided 15 mA 
during stacking and 25 mA constant current after the tracking dye 
entered the separating gel. The gels were stained with Caomassle 
Brilliant Blue dye (1.2 g/1) in Isopropanol:glacial acetic add:water 
(1:1:8). Destainlng was done using the same solvent. Silver staining 
was done by a modification of the method of Switzer et al. (1979). The 
gels were loaded with 10 pg protein from XM-100 or YM-100 washed 
retentates of TL culture supernatants, or with 200 ng purified SMAL. 
After electrophoresis the gels were fixed in methanol:water:glacial 
acetic acid (5:5:1) for at least 2 hr, were then washed with deionized 
water for 15 min followed by staining for 45 min in a solution of 5.9 mM 
AgNO^, 31 mM NH^OH and 2 mM NaOH. After washing the gels three times 
with deionized water (5 min each time), proteins were visualized by 
developing the gels in a solution containing 0.05% citric acid and 0.02% 
formaldehyde. Molecular weight standards (Pharmacia) Included 
phosphorylase b (94,000 d.)f bovine serum albumin (67,000 d.), ovalbumin 
(43,000 d.), carbonic anhydrase (30,000 d.), trypsin Inhibitor 
(20,100 d,), and alpha-lactalbumin (14,400 d.). For detection of DNA,
1% agarose or 10% polyacrylamide gels were loaded with 20 pi of 
40-50-fold concentrated (XM-100 retentate) TL culture supernatant or
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5 ng purified SMAL calculated as protein. After electrophoresis (100 V, 
38 mA for 50 min), the gels were stained for 30 min In ethldlum bromide 
(0.5 pg/ml), and examined under UV light (Manlatis et al., 1982).
Elution of SMAL from Native Polyacrylamide Gel Electrophoresis by 
Electroblotting to DEAE-cellulose Paper. TL culture supernatant 
concentrated on a YM-100 membrane was treated with DNase, dialyzed 
against 0.05 Trls buffer pH 7 and subjected to 10% PAGE electrophoresis 
under native conditions. A Bio-Rad mini-vertical model 360 slab gel 
(1.5 mm thick) electrophoresis apparatus (8 cm x 8 cm) was used. A 
total of 250 yl (250 pg) of TL culture supernatant was applied to 
5 wells of the stacking gel. After electrophoresis (about 150 min at 
20 mA) the gel was placed against a sheet of DEAE-cellulose paper and 
electroblotted for 5 hr at 200 mA using a Hoeffer Scientific Instrument 
TE Transphor Electrophoresis unit. The buffer used for electroblotting 
contained 25 mM Trls, and 192 mM glycine HC1, adjusted to a pH of 8.3. 
After electroblotting, the DEAE-cellulose paper was cut to strips 1 cm 
wide, which were placed in 15 ml of 1 M NaCl at 4“C overnight. The 
substances eluted by the solvent were first -dialyzed against PBS,
3
followed by RPMI-1640 and then assayed for inhibition of H-tdr uptake 
using EL-4 or CEM-CM^ cell lines as target cells.
Protein Determination. Protein was determined by the method of 
Bradford (1976) using bovine serum albumin as standard.
3
Blonssay for Suppression of H-tdr Uptake by EL-4 Cell. Assays 
were done In triplicate similar to those described above. Each well 
received 0.1 ml of the actively growing cell suspension adjusted to
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4-6 x 10^ cells/ml and 0.1 ml of fllter-sterllized TL culture 
supernatant or other samples which had been equilibrated with RPMI-1640 
by ultrafiltration or dialysis. The plates were Incubated for a minimum
3
of 22 hr before the addition of 1 pCi of H-tdr (6 Cl/mmole) to each 
well. The plates were Incubated another 2 hr, after which the cells 
were harvested as described In the assay for suppression of activated 
PBL. Controls consisted of cells cultured with medium In the absence of 
TL culture supernatant. Suppression of the uptake and Incorporation of 
radioactivity was calculated using the formula given above.
Assignment of SMAL Unit. The quantity of SMAL was estimated using 
serially diluted TL culture supernatants or other samples which were
3
subjected to bloassay for the suppression of H-tdr uptake by EL-4 cells 
as described above. Data were plotted on probability papers as function 
of X suppression vs. reciprocal of the dilution. The reciprocal of 
dilution that resulted In SOX suppression was used as the number of 
unlts/0.1 ml of the tested sample. The amount of SMAL that results in
3
5OX Inhibition of H-tdr incorporation Is assigned one unit.
Inhibition of Production of SMAL by Cycloheximlde and Heat. 
Suspensions of TL were prepared at 10 x 106 cells/ml and were divided 
Into experimental and control groups. The experimental groups were 
either treated with cycloheximlde (100 pg/ml) during culture or were 
killed by heating to 56°C for 1.5 hr before culture. The control were 
comprised of normal untreated TL cells. Each group then was cultured 
for four days in TL culture medium.
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Fractionation of T and B Lymphocytes. T enriched- and B 
enriched-lymphocyte fractions were prepared from TL on a discontinuous 
gradient of Fercoll according to Gutierrez et al. (1979). Each of the 
two fractions was then washed once with TL culture medium, sedlmented at 
400 x g for 10 min, and resuspended at a cell density of 10 x 10^/ml in 
TL culture medium. The cells were grown four days and the culture 
supernatants were assayed for the amounts of SMAL units as described 
above.
The spontaneous proliferation of the TL and the T enriched- and B 
enriched-lymphocyte fractions was measured by suspending 4 x 106 cells 
in TL culture medium (1 ml total volume) in tissue culture tubes. The
3
cells were pulsed with 4 pCi H-tdr (6 Cl/mmol) for 24 hr. The cells 
were pelleted at 400 x g for 10 min, resuspended in 51 TCA allowed to 
stand for 15 min, and harvested on GF/C filter paper. The paper was 
washed five times with 51 TCA and finally with 70% ethanol, and air
3
dried. H-tdr cpm were determined as described above.
Effect of Various Treatments on the Activity of SMAL. XM-100 
retentates of TL culture supernatants were treated in various ways to 
determine treatment affects on the activity of SMAL. Retentates were 
examined for thermal stability by heating 1 ml of 40-fold concentrated 
supernatant in a capped pyrex culture tube in a water bath at 56®C,
70®C, or 100°C for 1 hr. The samples were dlalyzed against TL culture 
medium, filter-sterilized, and assayed for suppressive activity. The 
control was the unheated supernatant fluid treated similarly. XM-100 
retentates washed with PBS were dlalyzed overnight in 0.2 M glyclne-HCl, 
pH 2, or made 0.4 M in HC1, 10% in TCA, 6 M in urea, or 60% in
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acetonitrile. The acida caused precipitation, so the precipitates and
their supernatants were assayed. The samples were dlalyzed first in
PBS, then TL culture medium, and assayed as above. XM-100 retentates In
RPMI-1640 were digested with pronase (45 units/ml; 70 unlts/mg;
Calbiochem), deoxyribonuclease I (130 Mg/ml; 2621 units/mg; Sigma) or
rlbonuclease (14 mg/ml; 300,000 unlts/mg; Milllpore, Inc.) for
2.5-3.0 hr at 37°C. After digestion, the samples were washed on an
YM-100 ultrafilter several times, adjusted to the correct volume, and
assayed for percent suppression compared to the untreated control. As a
control for the assay, the same amount of pronase, DNase, or RNase were
added to EL-4 cells.
Solid NH.SO, was added to 5-10 ml of 100-fold concentrated XM-100 4 4
retentate in PBS at 5“C. The precipitates which formed at 03-40%,
403-80%, and 80%-100% saturation were recovered at 4°C in centrifuge at
20,000 x g for 30 min. Precipitates were dissolved in PBS, dlalyzed
against large volumes of PBS and finally TL culture medium. Dlalysate
3
were then subjected to bioasaay for percent suppression of H-tdr uptake 
by EL-4 cells.
DEAE-anlon Exchange Chromatography. DE-52 (Whatman) was washed, 
equilibrated in start buffer (0.05 M Trls-HCl, pH 8), and packed under 
25 cm pressure in a K 9/15 column (Pharmacia). One to two ml of XM-100 
retentate of TL culture supernatant (2-6 mg protein) equilibrated in 
start buffer were loaded on the column. The column was flushed with two 
volumes (20 ml) start buffer before commencing a linear gradient with 
1 M NaCl in start buffer using a gradient former. The flow rate was 10 
ml/hr. Conductivity of the fractions (2 ml/tube) was determined with a
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Radiometer CDM 2 meter, while the optical density of each fraction was 
determined at 280 nm. Fractions were pooled as shown in Figure 11, 
dlalyzed against PBS, concentrated to the volume loaded on the column by 
using a YM-10 ultrafilter, and then analyzed.
Absorbance of Ion-Exchange Pooled Fractions. Pools 1, 2, and 3 
resulting from DEAE chromatography and purified SMAL from HPLC (see 
below) were scanned for their absorbance of light between 240 and 300 nm 
using a Beckman Model 35 Spectrophotometer attached to a recorder. The 
samples were In start buffer or TL culture medium.
Ion-exchange HPLC. Two to eight mg of protein (2 ml) of XM-100 
retentates of TL culture supernatants which were treated with 
deoxyribonuclease I as described above were loaded onto a QMA-Accell 
anion exchange column (Waters Associates) previously equilibrated with 
start buffer. The column was attached to two Waters Model 510 HPLC 
pumps using a flow rate of 2 ml/mln. After a 25 min lsocratlc elution, 
a linear gradient of 0 to 1 M NaCl In start buffer commenced and was run 
for 45 min using a Waters Automatic Gradient Controller. The NaCl was 
held at 1 M for an additional 25 min of the 95 min total running time. 
The optical density of the eluate was monitored at 280 nm by a Waters 
Lambda Max LC Spectrophotometer attached to a Data Module set at a chart 
speed of 0.2 cm/min. Fractions collected (2 ml) were pooled, 
concentrated on a YM-10 ultrafilter and analyzed by SDS-PAGE or
3
subjected to bloassay for the suppression of H-tdr by EL-4 cells.
3 3 3Assay for the Uptake of H-tdr, H-udr, and H-adr. Actively
growing EL-4 cells (0.1 ml at 6 x 10^ cells/ml) were added to triplicate
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wells of 96-well tissue culture plates (Coscar with flat bottom) 
followed by 0.1 ml of SMAL (experimental) or RPMI-1640 (control).
Plates were incubated for 24 hr at 37"C and then pulsed with either 
1 MCI of 3H-tdr (6 Ci/mmol), 3H-udr (15 Ci/mmol)f or 3H-adr 
(50 Ci/mmol). At different time Intervals samples were harvested on 
GF/C filter papers using a MASH-II multiple harvester (Microbiological 
Associates). The filters were dried and placed in plastic mini-vials 
containing four ml Sclntisol, and radioactivity was determined in a 
Beckman 3155T scintillation counter.
3
Incorporation of H-tdr into Acid-insoluble and Acid-soluble 
Materials. EL-4 cells were cultured in the presence and absence of SMAL
3
as described above followed by pulsing with 1 pCi of H-tdr for an 
additional 2 hr. The cell suspensions were transferred to 1.5 ml 
Eppendorf tubes and washed three times with 1, ml of cold RFMI-1640 (30 
second 13,000 x g). Duplicate samples of the cell pellet were 
resuspended in 200 pi of cold 5% TCA followed by centrifugation at
13,000 x g for 5 min. Fifty microliter aliquots of the supernatants 
(TCA soluble) were added to plastic mini-vials containing four ml of 
sclntisol. The TCA-precipitable material was resuspended in 5Z TCA and 
harvested on GF/C filters. Filters were washed five times with 5X TCA 
followed by a final rinse with 70Z ethanol. Radioactivity was 
determined as described above.
3
To study the effect of increasing concentration of H-tdr on the
3
incorporation of H-tdr by control and SKAL-treated cells, actively 
growing cells were cultured in the presence and absence of SMAL for 
24 hr as described above. They were then pulsed for 2 hr with
24
3
increasing concentrations of H-tdr (up to 6 pH) and the extent of 
incorporation was determined.
Effect of 5-Fluorodeoxyuridine on the Growth of EL-4 Cells in the 
Presence and Absence of SMAL. Actively growing EL-4 cells were cultured 
in the presence and absence of SMAL for 24 hr. Different concentrations 
of 5-Fudr were then added to each well and after an additional 48 hr 
incubation the number of cells were determined using a heraocytometer. 
Control cultures contained cells that were grown in the absence of SMAL 
and 5-Fudr. For calculating the percent of growth Inhibition, the 
original cell concentration of the experimental cultures was subtracted 
from its final cell number and was applied to the 
following formula.
Cell number experimental
% Growth Inhibition - < 1-   ) X 100
Cell number control
3
Binding of H-HBTI to EL-4 Cells. EL-4 cells were grown in the 
presence and absence of SMAL for 24 hr and then were pulsed with 1 pCi 
of 3H-nitrobenzylthioinosine (3H-NBTI) (20 Cl/mmol) (Moravek 
Biochemical, Brea, Ca) for and additional 30 min at 37°C or 25°C. The 
cells were harvested on GF/C filter papers and washed 5 times with 
ice-cold buffer (0.05 M Tris HCl pH 7.5) and radioactivity was
3
determined as above. Non-specific binding of H-NBT1 to cells was 
calculated by Including in the experiment cells that received a high 
concentration of unlabeled NBTI (50 pM) prior to the addition of labeled
3
H-NBTI and subtracting these values from those obtained in the presence 
of 3H-NBTI only.
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Thymidine Kinase Assay. EL-4 cells were grown in the presence or
absence of HPLC-purlfied SMAL for 24 hr (10 ml total volume). Cells
were counted and then harvested by centrifugation at 500 x g for 15 min
at 5°C. The pellet was washed once with ice cold RPMI-1640, resuspended
in 1 ml of buffer containing 0.05 M Trls pH 7.5 and 5 mM MgCl^ and were
then sonicated (3 pulses of 10 Becond) with Branson cell dlsruptor Model
185. Cell debris was removed by centrifugation at 500 x g for 15 min
followed by a second centrifugation at 100,000 x g for 1 hr. The
supernatants obtained after the second centrifugation were used
immediately for TK assay. Enzyme activities were determined by
3
following the phosphorylation of labeled H-tdr according to the 
procedure of Madhav et al. (1980). The reaction mixture contained cell
extracts (70 |ig of total protein) in 0.05 M Tris HC1 pH 7.5, 5 mM MgCl^,
3
10 mM ATP and 1 pCi H-tdr (6 Cl/mmol) in a total volume of 0.1 ml.
After 30 min incubation at 37°C, 25 to 50 pi aliquots of the duplicate 
samples were spotted on 2.5 cm discs of DEAE-cellulose paper (DE-81).
The discs were placed Into individual beakers containing 30 ml of 90% 
ethanol, were washed five times (10 min each) with 30 ml ethanol, dried 
and placed in plastic mini vials containing 4 ml of Sclntisol 
Radioactivity was determined by a liquid scintillation counter.
Determination of DKA Content and Autoradiography of SMAL-treated 
EL-4 Cells. Logarithmically-growing EL-4 cells (4 x 10^ cells/ml) were 
cultured in the presence and absence of SMAL for 24 hr. Small aliquot 
(0.1 ml) of cell suspensions were removed and placed in tubes containing 
5 ml of fixative solution consisting of methanol, and acetic acid (3:1). 
Cells were washed twice in this solution. The cell pellets were
26
resuspended in 200 pi of the fixative and smeared across the microscope 
slides. After the slides were air dried, they ware stained with Feulgen 
reagent for DNA. A Vickers-H86 scanning and integrating 
microdensitometer (Vickers Instruments Inc., Malden, MA 02148)
Interfaced to a Sol system IIIA microcomputer was used to determine net 
absorbance of the Feulgen-DNA complex in individual nuclei. All 
measurements were performed as described by Lee and Rasch (1984). 
Approximately 200 nuclei were scanned for each slide.
For autoradiography, the remaining cell suspension were pulsed for
3
1 hr with 4 pCi/ml of H-tdr (6 Cl/mmol). Samples taken at the end of 
1 hr were considered to be zero time samples. The rest of the cells 
were washed with RPMI-1640 three times resuspended In fresh medium 
containing 10% FBS and incubated at 37°C. These cell suspensions were 
sampled at various subsequent time intervals to prepare microscope 
slides as described above.
Slides were then dipped Into Kodak nuclear track emulsion type 
NTB-2 in the dark and were exposed at 4°C in a light proof container for 
24 hr. Slides were developed in Kodak D19 developing solution and 
stained with Giemsa. The background was less than 3 grains per nucleus, 
and nuclei with 5 or more grains were regarded as labeled. About 1000 
nuclei per each slide were counted under the microscope to determine the 
percentage of labeled nuclei.
Determination of Cytopathic Effect of HSV II on MRC and HEP-2 Cell 
Line in the Presence or Absence of SMAL. Actively growing MRC or HEP-2 
cell lines were cultured in 96-well microtiter plates with flat bottoms
5
at concentration of 2 x 10 cells/ml In RPMI-1640 In the presence of 10% 
FBS. Serial dilutions of SMAL were added to each well, and the plates 
were Incubated for 24 hr at 37®C. At the end of 24 hr, serial dilutions 
of a clinically isolated HSV II (obtained from the Department of 
Microbiology, Quillen-Dishner College of Medicine, ET5U) were added to 
the cells and the plates were Incubated for several days at 37®C. At 
24 hr Intervals, the cells were observed for cytopathlc effect (CPE) 
using an Inverted microscope. The extent of CPE was recorded on a scale 
from +4, meaning extensive damage and rounding up of the cell 
monolayer, to a negative sign (-) meaning no cellular damage.
CHAPTER 3 
Results
Tonsil Lymphocyte Culture Supernatant Suppresses the Uptake of
3
H-tdr by Con A-Stimulated Lymphocytes and EL-4 Cells* Human tonsil 
lymphocytes were cultured In medium for 24 hr. The supernatant culture 
fluid was dlaly2ed and lyophillzedt and then tested for its effect on
3
the Incorporation of H-tdr by con A-stlmulated PBL or EL-4 cells. The
3
data are presented In Table 1. The uptake of H-tdr by con A-stlmulated 
human PBL and by xenogeneic mouse thymoma EL-4 cells was considerably 
reduced by tonsil lymphocyte culture supernatant. The extent of 
inhibition ranged from 94% to 98% for PBL and 76% to 94% for EL-4 cells. 
This suppressor of mitogen activated lymphocytes was referred to by its 
acronym* SMAL.
Determination of Growth Curve for EL-4 Cells. EL-4 cells were 
cultured for 5 days in antibiotic supplemented RPMI-1640 containing 10%
5
FB5 at Initial cell density of 2 x 10 /ml. At different time Intervals 
small aliquots of cell suspension were removed* and cell density was 
determined using a hemocytometer. As it is shown in Figure I* the 
doubling time for EL-4 cells was about 18 hr. This Information was 
necessary for using EL-4 cells as targets for bloassay of TL culture 
supernatant.
Kinetics of Inhibiton of ^H-tdr Uptake by EL-4 Cells Treated with
SMAL. The relationship of exposure time of EL-4 cells to SMAL and the 
3
suppression of H-tdr uptake was Investigated. Cells were incubated
28
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TABLE 1. Inhibition of the Uptake of
3
H-tdr by Con A-Stlmulated Human PBL 
and Mouse EL-4 Cells in the Presence of 
TL Culture Supernatant (SMAL)
3 -3Uptake of H-tdr (mean cpm x 10 ± SD)
__________PBL_____________ ______________EL-4_________________
Exp.
A 1)No. Control Experimental Control Experimental
I 37 ± 1.2 1.2 + 0.1(98)c 402 ± 9 23.3 ± 1.7 (94)
II 40.4 ± 3.5 3.5 ± 0.2(91) 178 ± 17 12.4 ± 1.4 (76)
a PBL vere cultured in TL medium containing an optimal dose of con A 
(control) or TL culture supernatant (experimental), 
k EL-4 cells vere cultured in TL medium (control) or TL culture 
supernatant (experimental). 
c X suppression
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Figure 1. Growth Curve of EL-4 Cells. Cells vere cultured at an
C
Initial density of 2 x 10 /ml In TL medium supplemented with 10Z FBS. 
At different time Intervals aliquots of all cell suspensions were 
removed to determine the cell concentration by a hemocytometer.
2 • 3
Time (days)
31
3with SMAL and Che uptake of H-tdr at various tines was determined. As 
It Is shown In Figure 2 a minimum of 6 hr exposure of EL-4 cells to SMAL
3
was necessary In order to detect substantial Inhibition of H-tdr 
uptake. Suppression, however, reached to Its maximum by 24 hr.
Fractionation of Tonsil Lymphocyte Culture Supernatant by 
Ultrafiltration. Tonsil lymphocyte culture supernatant was subjected to 
serial fractionation using Amicon Diaflo ultrafilter membranes with M.W. 
cut—offb of 300 kd. (XM-300), 100 kd. (XM-100), 50 kd. (XM-50), 10 kd.
(YM-10), and 2 kd. (YM-2). The retentate from each membrane fraction
3 3 3then was tested for the inhibition of H-tdr, H-udr or H-Leu uptake by
EL-4 cells. Only retentates of XM-100 membrane could inhibit the uptake
of ^H-tdr by EL-4 cells (65%). No inhibition of ^H-Leu uptake was
3
noticed with an XM-100 retentate, but the uptake of H-udr was also 
suppressed (35%) (Table 2).
Assignment of SMAL Unit. EL-4 cells were cultured in the presence
of varying concentrations of TL supernatant for 22 hr and were pulsed
3 3
with H-tdr for 2 hr. The inhibition of the H-tdr incorporation in the
cells was dependent on the dose of TL culture supernatant (Fig. 3A).
The data were subjected to a Probit analysis. When percent inhibition 
3
of the H-tdr incorporation was plotted against reciprocal of serial
dilution of a sample, the activity of SMAL could be defined by the
reciprocal of dilution of the sample that resulted in a value of 50%
inhibition (Fig. 3B). Therefore, one unit is that amount of SMAL which
3
results in 50% suppression of H-tdr uptake by EL-4 cells. Based on 
this assay, typical TL culture supernatants usually contained 
2-10 units/ml of SMAL.
32
3
Figure 2. Time Course Effect of SMAL on Che uptake of H-tdr into
4
EL-4 Cells. EL-4 cells (4 x 10 per well) taken from mid-log phase of 
growth were placed in the wells of a microtiter tissue culture plate 
essentially as described for the assay for suppression of EL-4 cells,
3
except that H-tdr was added 2 hr before each harvest time point.
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TABLE 2. Fractionation of TL Culture Supernatant by 
Dlaflo Ultrafiltration
Membrane Type
XM-300 XM-100 XM-50 YM-10 YM-2 YM-2Flltrate
Labeled
Substance
Incorporated _________Inhibition of Incorporation (it)
H-tdr 0 65 0 0 10 0
3H-udr ND 35 0 0 0 0
3H-Leu ND 0 NDS ND ND ND
TL culture supernatant was subjected to serial ultrafiltration starting 
with the largest pore-slze membrane. After each retentate was 
concentrated to 40-fold, it was subjected to bioassay using EL-4 cells 
as target. 
a Not Done
3 4
Figure 3. Assignment o£ SMAL Unit. Figure 3A, activity of serial
dilutions of the TL culture supernatants were assayed against EL-4
cells as described in Materials and Methods. Figure 3B, Probit
plotting of the data in Figure 3A provided units of SMAL activity.
One unit is the amount of SMAL which causes 50% inhibition of 
3
incorporation of H-tdr.
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Characteristics of the Production of SMAL. Four types of 
experiments were performed to investigate certain characteristics of the 
production of SMAL by TL. Suspensions of TL were divided into a control 
group and two experimental groups. The experimental cultures were 
treated with cyclohexlmlde during culture or were heat killed before 
being cultured. The culture supernatants were collected and assayed for 
SMAL. There was no activity in the culture fluid of the heat-killed 
cells or the cells cultured with cyclohexlmlde (Fig. 4). The untreated 
TL produced about 200 units of SMAL/100 ml of culture supernatant.
For the second experiment, TL were cultured at 4 X 10® cells/ml for 
24 hr. The supernatant was collected and the cells were* resuspended in 
fresh medium. After another 24 hr culture, the process was repeated, 
and with the collection of the third 24 hr culture supernatant, the 
cells were discarded. The XM-100 retentates of the three culture 
supernatants were assayed against EL-4 cells. As shown in Figure 5 
maximal production of SMAL occurred during the first 24 hr period, and 
the production diminished during each subsequent 24 hr culture period.
TL were cultured at several cell densities for 24 hr In the third 
experiment. The production of SMAL in these respective culture 
supernatants Increased with increasing cell densities (Fig. 6). At cell 
densities of 2 X 10® cells/ml or less, however, there was no detectable 
suppressive activity. In the fourth experiment TL at 10 X 10** cells per 
ml were cultured 1, 3, or 5 days. The units of SMAL in their 
supernatants Increased with the culture time (Table 3) as predicted by 
Figure 5; 70% of the amount of SMAL found after 5 days of culture was 
produced within the first 24 hr of culture.
36
Figure 4. Production of SMAL by Heat-killed or Cyclohexlmlde-treated 
TL. TL were cultured with cyclohexlmlde (100 yg/ml), or were placed 
in TL Culture medium after being killed by heating to 56“C, or were 
cultured untreated (none). The supernatants of the three cultures 
were assayed for units of SMAL.
UN
ITS
 
OF
 
S
M
A
L/
10
0 
m
l
<
H
<
2
OC
LD
Q.
ID
CO
HI
cc
z>
l-
-J
z>
o
2 0 0
150
100
50
NONE HEAT
KILLED
TREATMENT OF TONSIL
: CYCLOHEXIMIDE
*
LYMPHOCYTES
37
Figure 5. Kinetics of the Appearance of SMAL in the culture 
Supernatants of TL. The cells were cultured at 4 x 10^ cells/ml for 
three days, but the culture supernatants were collected every 24 hr 
and fresh TL culture medium was added to the cells. The supernatants 
were assayed for units of SMAL.
UNITS OF SMAL/100 ml CULTURE SUPERNATANT
roo coo o
10
o<z
1“
-Ic
DOm
2
o
D
CO
Oo o o
o
ro
co
4
38
Figure 6. Production of SMAL as a Function of TL Cell Density. TL 
were cultured at different cell densities as indicated. The culture 
supernatants were harvested and assayed for units of SMAL at the end 
of the culture period.
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TABLE 3. Accumulation of SMAL 
During Uninterrupted Culturea
Length of Culture SMAL
(days)
Jj
(units/100 ml Supernatant)
1 700
3 825
5 1000
a TL vere cultured 1, 3* or 5 days at a beginning density of
10 x 10^/ml. At the end of culture, the supernatants were assayed
against EL-4 cells.
-L
Units of each time point are accumulative.
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Culture Supernatants from Tonsil T and B Lymphocyte-enriched
Fractions Contained SMAL* TL and the T lymphocyte- and H
lymphocyte-rich fractions were cultured In small tubes for 24 hr and
3
their Incorporation of H-tdr was determined. It was clearly evident 
that tonsils contained lymphocytes which synthesized DNA spontaneously 
(Table 4) as compared to unstimulated FBL which did not Incorporate
3
H-tdr. Several experiments of this kind showed that the extent of 
thymidine Incorporation was quite variable, however, and thus the extent 
of spontaneous DNA synthesis by TL was unpredictable. The data In 
Table 4 also Indicated that the T and B lymphocyte-enriched fractions
3
Incorporated K-tdr. The B lymphocyte fractions Incorporated over twice 
3
as much H-tdr as the T lymphocyte fractions. The ratio of B lymphocyte 
to T lymphocyte cpm seemed to hold regardless of the ability of the
3
unfractionated TL to Incorporate H-tdr.
In other experiments, the T lymphocyte- and B lymphocyte-rich 
fractions were cultured at 10 x lO*’ cells/ml for 4 days. The culture 
supernatants were then collected and assayed for SMAL. The XM-100 
retentates of each culture supernatants inhibited the Incorporation of
3
H-tdr by EL-4 cells up to 852-90% (Fig. 7). The supernatant of the 
cultured T lymphocyte fraction contained 1200 units of SMAL/100 ml, but 
that of the B lymphocyte fraction contained 6400 units/100 ml.
Presence of SMAL-like Activity in the Tonsil Lymphocyte Sonicate. 
Tonsil lymphocytes prepared as described previously were resuspended at 
5 x 10^ cells/ml In RPMI-1640 and were lysed by sonicatlon. After 
centrifugation at 100,000 x g the supernatantB were dlalyzed on an
41
TABLE 4. Spontaneous Proliferation of 
Tonsil T and B Enriched Lymphocytes
3 aH-tdr Incorporation cpm
Experiment No. Unseparated TL T Lymphocytes B Lymphocytes
I 52,200 42,000 107,000
II 55,600 41,000 100,500
III 11,000 11,000 26,000
a Several experiments indicated that unstimulated FBL did not 
3
incorporate H-tdr and had a mean cpm of 1000.
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Figure 7. Production of SMAL by T Cell-enriched and B Cell-enriched 
Tonsil Lymphocyte Preparations. Tonsil lymphocytes were separated to 
B and T cell-enriched populations by Percoll density gradient 
centrifugation as described in Materials and Methods. The cultures 
were Incubated for four days and the culture fluids were collected and 
assayed for SMAL. •—  T-cell culture fluids, o—  B-cell culture 
fluid.
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XM-100 membrane and subjected to bloassay using EL-4 cells. The percent 
3
of inhibition of H-tdr incorporation by TL sonicates ranged from 86 to 
92% in different experiments (Table S).
Effect of Various Treatments on the Activity of SMAL. XM-100
retentates of culture supernatants were subjected to various kinds of
treatment, and the residual activity of suppression of Incorporation of 
3
H-tdr by EL-4 cells was measured. Heating the retentate to 56°C for 
1 hr reduced its activity only 15%, but heating to 70®C reduced it by 
70%. The activity was totally abolished upon heating to 100°C 
(Table 6). Treatment of retentates with glycine (pH 2), HC1 or TCA 
caused precipitation. When the precipitates and their supernatants were 
assayed, about 85% of the activity of SMAL was recovered in the glycine 
supernatant, but no activity was recovered in any of the other 
supernatants or precipitates. Making the active XM-100 retentate of a 
culture supernatant 60% in acetonltrlle also resulted in complete loss 
of activity, but 6 M urea had no measurable affect (Table 6). The 
activity of SMAL was sensitive to pronase treatment, while HNase had no 
apparent effect. Treatment with DNase, however, enhanced the activity 
by 1.5-fold (Table 6).
Precipitation of SMAL Activity by Ammonium Sulfate. TL supernatant 
concentrated on XM-100 membrane was precipitated in a stepwise manner by 
ammonium sulfate. The majority of activity of SMAL was present in the 
40 to 80% ammonium sulfate saturation precipitate (Table 7). The 
recovery of SMAL activity was very poor, however, being less than 25% of 
Che original activity (Table 8).
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TABLE 5. Tonsil Lymphocyte Sonicate Inhibits
3
The Uptake of H-tdr by EL-4 Cells
3 -3
Uptake of H-tdr (mean cpm x 10 ± SD)
& bExperiment No. Control Experimental
I 97 ± 4 9 ± 4.8 <915C
II 131 +13 19 ± 0,18 (86)
III 92 ± 6 7 + 3  (92)
a Control EL-4 cells were cultured In the presence of culture medium 
only.
^ Experimental EL-4 cells were cultured In the presence of medium and TL
sonicate that had been washed on a XM-100 membrane with culture medium.
c 3Figures In parentheses represent X suppression of H-tdr uptake.
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TABLE 6. Stability of SMAL Activity to 
Different Treatment
Treatment % of Control
568C 1 hour 83
70°C 1 hour 30
100 °C 1 hour 0
Frcnase 0
DNase 149
RNase 102
glycine (pH 2) 85
HC1 (0.4 M) 0
TCA (10%) 0
Urea (6 M) 100
Acetonitrile (60%) 0
TABLE 7. Fractionation of SMAL Activity 
by Ammonium Sulfate Precipitation
46
Fractions_______________
Experiment Ho. 0-40a 40-80 80-100
1 20^ 40 25
2 40 87 40
3 NDC 53 0
4 13 40 28
5 ND 73 ND
a
X Ammonium sulfate saturation
b 3X Suppression of H-tdr Incorporation
c Hot done
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TABLE 8. Purification of SMAL by Ammonium Sulfate 
Saturation Precipitation
Protein Activity SA^ Purification Recovery
Step mga/ml Unit a/ml Units/mg protein  Fold %
Crude 1.8 160 89 1.0 100
40-80% 0.75 40 53 0.6 25
a Solid ammonium sulfate was added to a solution of TL culture 
supernatant (100-fold concentrated) under constant agitation and the 
mixture was kept for 4 hr at 4BC. The material precipitated between 
0 to 40% was pelleted by centrifugation at 12,000 x g for 20 min, 
resuspended in PBS and dlalyzed against PBS. To the remainder of the 
solution solid ammonium sulfate was added and the precipitation process 
was repeated. Each fraction then was dlalyzed against RPMI-1640 and 
subjected to bloassay for SMAL against EL-4 cells, 
k Specific activity.
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Partial Purification of SMAL by Molecular Sieve Chromatography. It
was determined earlier that the suppressive activity In TL culture
supernatants eluted from columns of Sephadex G-100 at Vq (Hodge and
Inman, 1982). Other attempts were made to resolve SMAL by molecular
sieve chromatography using Bio-Gel A-0.5 m and Fractogel TSK 55S. The
3
fraction most active in suppressing incorporation of H-tdr into EL-4 
cells eluted at VQ using the A-0.5 m medium, hut various amounts of 
suppressive activity were detected in pooled fractions throughout the 
profile with subsequent uses of the same column. In contrast, when 
culture supernatants were filtered through Fractogel, SMAL activity on 
EL-4 cells (see below) was associated with pooled fractions whose peak 
M.U. were about 630,000, 148,000, and 16,000 (Fig. 8 and 9).
Since the TSK 55S elution profile indicated that SMAL could have a 
M.U. as low as 16,000, the volumes of culture supernatants were reduced 
by filtration through a YM-10 ultrafilter. This ultrafilter should have 
retained the SMAL. The retentates were diluted and reconcentrated on a 
YM-100 ultrafilter which retains proteins of M.U. about 100,000. The 
original YM-10 retentates and the YM-100 retentates were examined by 
native PAGE. The patterns were very similar and clearly showed protein 
heterogeneity in the retentates (Fig. 10). The units of SMAL recovered 
in the YM-100 retentate were 95% of those in the YM-10 retentate. The 
reduction of culture supernatant volumes was much more rapid using 
XM-100 or YM-100 ultrafilters than YM-10 ultrafilters with no 
differences In protein content or SMAL activity. Therefore, we 
routinely used the larger pore ultrafilters for this purpose. The 
retention of SMAL by the XM-100 ultrafilters was consistent with the
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Figure 8. Calibration of Fractogel TSK 55S Molecular Sieve Column* 
The column was equilibrated and packed in 0.05 M Tris HC1 and 0.5 M 
NaCl pH 8 at flow rate of 19 ml/hr. The column then was calibrated 
with the following standards. A. Myoglobin (17,200), B. Aldolase 
(158,000), C. Catalase (232,000), and D. Ferritin (440,000). Column 
size (1.5 x 90 cm). Fractions of 2 ml were collected.
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Figure 9. Fractionation of SMAL by TSK 55S Molecular Sieve Column 
Chromatography. An aliquot of 1 ml of TL culture supernatant 
(concentrated to 100-fold on XM-100 membrane) containing 2 mg of 
protein was applied to the column. Fractions of 2 ml were collectedf 
pooled as shown and concentrated on YM-10 membrane. After dialysis 
against RPMI-1640 they were subjected to assay for SMAL. Bars 
represent pooled fractions having SMAL activity.
Fraction 
number
Absorbance (O.D. 280 nm)
P • P r09
Blue Dextran
u>o
Ferritin
Catalase
Aldolase
Myoglobin
in
O'
to
to
Oo
SMAL (Units/ml)
51
Figure 10. Native Polyacrylamide Gel Electrophoresis of TL 
Supernatants Concentrated on YM-10, or YM-100 Dlaflo Membranes. TL 
supernatant was concentrated by ultrafiltration using Amicon membranes 
YM-10 or YM-100. A portion of YM-100 retentate was treated with 
DNase. Fractions were subjected to 10Z polyacrylamide gel 
electrophoresis under native conditions and stained with Coomassie 
blue. Lane 1, YM-10 retentate; lane 2, YM-100 retentate DNase 
treated; and lane 3, YM-100 retentate.
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the data obtained by molecular sieve chromatography for a H.W. In excess 
of 100,000.
Purification by Anion Exchange Chromatography. YM-100 retentates 
were applied to a DE-52 column. The elution profile showed some 
material (Fig* 11, pool 1) did not adhere, but there were two optical 
density peaks of adhering components that were detected after their 
elution by salt. Fractions 3-12 were pooled, and fractions with 
conductivities of 2-14 mHhO and 18-30 mMhO which eluted after the salt 
gradient commenced were pooled as indicated on Figure 11. Neither pool 
1 nor pool 2 assayed positive for SMAL. The activity of SMAL, however, 
was almost always associated with pool 3 and based on numerous 
experiments like this, SMAL activity usually eluted between 18-30 mMho. 
Six mg of protein containing 1120 units of SMAL in 1 ml of a YM-100 
retentate of culture supernatant were loaded on the column (Fig. 11 and 
Table 9). Fool 3 (Fig. 11) contained 0.9 mg protein and 288 units of 
SMAL. Its specific activity was 320 units SMAL/mg (Table 9). Only 15% 
of the loaded protein eluted in pool 3, but 26% of the total activity of 
SMAL was recovered in this pool. This constituted 1.7-fold purification 
of the units of SMAL (Table 9).
The YM-100 retentate (Table 9) and pool 3 (Fig. 11) were subjected 
to SDS-FAGE and then stained with silver. The protein content of the 
retentate was very heterogeneous with stained bands which were 
distributed throughout the gel (Fig. 12, lane 2). Fool 3, on the other 
hand, was much less heterogeneous, and the smallest component was about 
Mr 25,000 (Fig. 12, lane 3). The most heavily stained component of both 
samples was about Mr 43,000. Since both samples were retentates of
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Figure 11. Elution Profile of TL Culture Supernatant Fractionated on 
a Column of DEAE-cellulose. TL culture supernatants were concentrated 
on YM-100 membranes, applied to a DE-52 column and eluted with a 
linear gradient of salt ranging from 5 to 35 mMHO (solid line).
Pooled fractions (2 ml per tube) were assayed for SMAL as described in 
Materials and Methods. Pool 1, fractions 3-12; pool 2, fractions 
17-24; pool 3, fractions 28-38. Shaded area denotes SMAL activity per 
ml of pool 3 after it was reduced in volume to equal that of retentate 
loaded.
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TABLE 9* Purification of SMAL by DEAE-Cellulose 
Ion Exchange Chromatography
Total Total Purlfl-
Volume Protein Activity S.A. Activity cation Recovery
Step ml (mg) Unlts/ml Units/mg Units fold X
Crude 1330 6.65 0.9 180 1197 1 100
YM-100a 10 6 112 186 1120 1.03 94
DEAE-
1-8 0.936 160 308 288 1.7 24
Cellulose*5
n
Tonsil lymphocytes culture supernatant was concentrated 133-fold by 
ultrafiltration using a YM-100 membrane,
^ Pool 3 from DEAE-cellulose anion exchange column.
S.A. Specific Activity
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Figure 12. SDS-PAGE Analysis of a YM-100 Retentate and Pool 3 from 
Anion Exchange Column. 50 pi of 130-fold concentrated YM-100 
retentate (30 pg total proteins) and 50 pi (30 pg) of pool 3 (Fig. 11) 
were loaded In lanes 2 and 3, respectively, electrophoresed and 
stained with silver. Lane 1 contained M.W. markers whose weights are 
Indicated in the figure. Lane 4 was loaded with buffer.
BSffSil
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an ultrafilter with a Mr 100,000 exclusion, It was likely that in the 
absence of denaturing substances, the proteins were polymerized.
The absorbance spectra of the three pools (cf. Fig. 11) was 
obtained. Pool 1 had an absorption maximum at 280 nm, but It was a 
broad absorbance extending down to about 262 nm (Fig. 13). Pool 2 
absorbed relatively strongly at about 275 nm but Its absorbance range 
also was broad. Pool 3 had an absorbance maximum at 258 nm, and ‘it also 
absorbed strongly at 280 nm. These data Indicated the presence of both 
proteins and nucleic acids In pool 3 and In the XM-100 retentates of 
cultured supernatants.
Detection of DNA In the Tonsil Lymphocyte Culture Supernatant by 
Ethldium Bromide Staining. The high absorbance at 260 nm of crude TL 
culture supernatant and pool 3 from DEAE-cellulose column indicated the 
presence of nucleic acid in these preparations (Fig. 13).
It was necessary to determine the nature of 260 nm-absorbing 
material In the concentrated crude TL culture supernatant. To do so, 
the effects of various chemical and enzymatic treatments were 
Investigated. As shown in Figure 14, the nucleic acid stainable with 
EtBr was sensitive to 0.45 M HC1, DNase, micrococcal nuclease, and TCA 
(lanes 3, 5, 6 and 8) but insensitive to RNase, and NaOH hydrolysis 
(Fig. 14, lanes 4, and 7), respectively. These results indicated that 
XM-100 retentates of crude TL culture supernatants contained DNA,
It was also necessary to find out if DNA per se had any suppressive
3
activity on the uptake of H-tdr by EL-4 cells. Calf thymus DNA (up to
2 mg/ml) was added to EL-4 cells for 24 hr after which the cells were
3 3assayed for H-tdr uptake. No Inhibition of H-tdr uptake was noted.
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Figure 13. Absorbance Spectra of Pooled Fractions. Pools 1, 2, and 3 
from a typical Ion exchange column fractionation of a YM-100 retentate 
of TL culture supernatant (Fig. 11) were scanned for their absorbance 
of light between 240 nm and 300 nm.
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Figure 14. Presence of DNA in the TL Culture Supernatant. XM-100 
retentate of TL culture supernatant was treated with DNase, RNase,
TCA, HC1, NaOH, and mlcrococcal nuclease (lanes 3-8) and after 
dialysis was subjected to agarose gel electrophoresis. The gel was 
stained with ethldium bromide and excited with fluorescent light for 
visualization of stained material. Lane 1 contained sample buffer, 
lane 2 contained untreated XM-100 retentate, lanes 3 through 8 
contained XU-100 retentate treated with HC1, RNase, DNase, mlcrococcal 
nuclease NAOH, and TCA respectively, lane 9 and 10 contained standard 
DNA plasmlc (PBR) and yeast tRNA, respectively.
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These data indicated that purified calf thymus DNA even at high
3
concentration did not inhibit the uptake of H-tdr by EL-4 cells.
Digestion of an XM-100 retentate with pronase caused complete loss 
of SMAL activity, but treatment with ribonuclease had no effect. 
Deoxyribonuclease treatment, however, significantly increased the 
suppressive activity (Table 6). This observation and the spectral 
absorbance data suggested SMAL might be associated with DMA.
Kinetics of Appearance of DNA in the Culture Supernatant of Tonsil
3
Lymphocytes. Tonsil lymphocytes were cultured in the presence of H-tdr 
for 24 hr. The supernatant was collected and the cells were washed and
3
placed in fresh medium in the absence of H-tdr and incubated up to 
5 days with changing the medium every 24 hr. Figure 15 shows the
3
appearance of TCA-precipitable H-tdr in the culture supernatant of 
tonsil lymphocytes as a function of time. The maximum amount of newly 
synthesized DNA was released into the culture fluid on day 3 of culture 
and subsequently reduced by day 4 and 5 of culturing.
3
H-tdr-Labeled DNA from TL Culture Fluid was not Taken up by EL-4
Cells. Since tonsil lymphocyte culture supernatants contained
substantial amountB of DNA, it was possible that during the incubation
of these supernatants with EL-4 cells the DNA was hydrolyzed and its
nucleotides were converted to nucleosides by phosphatases. The presence
of unlabeled tdr drived from DNA, therefore, could have resulted in a
substantial reduction in the specific radioactivity of the labeled 
3
H-tdr used in the bloassay for SMAL, and the resulting data would have
3
been interpreted as indicating inhibition of H-tdr incorporation.
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Figure 15. Kinetics of Appearance of Newly Synthesized DNA in the 
Culture Supernatant of TL. TL were cultured In the presence of 
4 pCl/ml of H-tdr for 24 hr. Culture supernatant was collected and 
the cells were washed and resuspended in fresh culture medium free of
3
H-tdr. Cells were Incubated up to 5 days, with changing the culture 
medium every 24 hr. A portion of each culture supernatant was 
precipitated by I0Z TCA, collected on GF/C filter paper and the amount 
of radioactivity incorporated to DNA was measured by a liquid 
scintillation counter.
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In order to Investigate this possibility, tonsil lymphocytes were 
cultured In the presence of H-tdr for 24 hr. The culture supernatant 
was collected and tested for TCA-precipitable DNA (Fig. IS). This
supernatant was then concentrated to 40-fold and washed with TL medium
3
on a Diaflo ultrafiltration membrane (XM-100). This H-tdr labeled TL
Supernatant was added to EL-4 cells for 24 hr and the cells were tested 
3for the uptake of H-tdr derived from labeled DNA. The results in Table 
10 demonstrated that EL-4 cells did not take up any of the H-tdr 
present in the labeled DNA.
Preparative Polyacrylamide Gel Electrophoresis of XM-100 Retentate 
Culture Supernatant. In order to determine which component separated by 
native polyacrylamide gel electrophoresis (Fig. 10) was responsible for 
the bioactivity of SMAL, concentrated (130-fold) tonsil lymphocyte 
culture supernatants treated with DNase were subjected to gel 
electrophoresis under native conditions. A total of 1.1 ml of the 
concentrated TL culture supernatant was applied to 11 polyacrylamide 
tube gels (0.1 ml/tube). After electrophoresis one of the gels was 
stained with Coomassie blue and each of the other 10 were cut Into 1-cm 
long pieces. Corresponding pieces were pooled, crushed to very small 
sizes (using a fixed 80-mesh screen) and eluted in PBS at 4°C overnight. 
Each fraction corresponding to a specific Begment of the gels was then 
dlalyzed, concentrated to 1 ml and subjected to bloassay for SMAL 
activity. There was no demonstrable biological activity in any of the 
fractions. This experiment was repeated, but replacing the tube gel 
with a vertical slab gel. After electrophoresis of TL supernatant the 
gel was electrobloted to a sheet of DEAE-cellulose paper.
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TABLE 10. EL-4 Cells did not take up 3H-tdr Labeled DNA 
Released by Tonsil Lymphocytes
__________Mean CPM ± S.D.________
3H-tdr-labeled TL culture fluid
(XM100 Retentate)________
0 I)Experiment No. Control Experimental
I 9 6 + 1 9  70 + 35
II 63 +17 72 ± 15
a 3Consisted of H-tdr-labeled tonsil lymphocyte culture
In the absence of EL-4 cells.
t. O
Consisted of H-tdr-labeled tonsil lymphocyte culture 
TCA-precipitable cpm) in the presence of 0.2 ml of EL-4 
cells/ml.
fluid incubated 
fluid (6,000
5
cells at 4 x 10
The DEAE-cellulose paper then was cut Into 6 pieces corresponding to 
1 cm-length segments of the gel and each was placed Into a beaker 
containing 1 M NaCl to elute the bound material. Each fraction then was 
dlalyzed, concentrated by ultrafiltration and subjected to bloassay for 
suppressor activity. No suppressor activity could be recovered from 
these fractions when EL-4 cells were used as target cells. However, 
when CEM-CM^ cell line were used as target cells, two regions of 
activity were recovered corresponding to 2 cm and 5.5 cm gel slices 
(Fig. 16B). As a background control, an identical gel was loaded with 
sample buffer and treated as described for the experimental gel. As can 
be seen In Figure 16A, there was no detectable suppressive activity 
associated with any of the control gel slices.
Purification of SMAL by HFLC. XM-100 retentatea of TL culture 
supernatants treated with DNase were chromatographed on a QMA-Accell 
column attached to HPLC equipment. A typical elution profile is shown 
in Figure 17A. Some material did not adhere to the column. Two peaks 
of protein eluted in the salt gradient with retention times of 56.89 min 
and 70.26 min. Fractions were pooled as indicated on Figure 17A, 
dlalyzed, and washed on an YM-10 ultrafilter. SMAL was associated only 
with the pooled fractions with retention time of 65 to 90 min. The pool 
was chromatographed again on the QMA-Accell column and the elution 
profile is shown in Figure 17B. Almost all the protein eluted in the 
salt gradient with a retention time of 70.45 min. This material was 
collected as shown on Figure 17B, and concentrated on a YM-10 
ultrafilter. It comprised 0.16 mg protein and 320 units of purified 
SMAL with a specific activity of 2000 units/mg (Table 11).
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Figure 16. Preparative Native Polyacrylamide Gel Electrophoresis of 
SMAL from YM-100 Retentate Treated with DNase. TL culture supernatant 
was concentrated on YM-100 membrane treated with DNase dialyzed and 
subjected to 10% polyacrylamide gel electrophoresis under native 
condition. The gel then was electroblotted to a sheet of 
DEAE-cellulose paper. The DEAE-cellulose paper was cut to 1 cm 
pieces. The materials bound to this paper were eluted with 1 M NaCl. 
Each fraction w s b  dialyzed against PBS then TL medium and subjected to 
bloassay using CEM-CM^ human T cell line as target cell. A. is 
control gel loaded with buffer and B. is experimental gel loaded with 
SMAL.
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. TABLE 11. Purification of SKAL by QMA-Accell 
Anion Exchange Column Attached to HPLC Equipment
Purification
Step
Total
Volume
ml
Total
Protein
mg
Total
Activity
units
S.A.a 
units/mg
Purification
fold
Recovery
X
XM-100 8 8 3200 400 1 100
QMA-Accellb 16 0.16 320 2000 5 10
HPLC
8 Specific activity.
b Pool 3 from QMA-Accell column (Fig. 17B).
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Figure 17. Purification of SMAL by HPLC. A QMA-accell anion exchange 
column was operated with HPLC equipment. A. sample chromatographed 
was an XM-100 retentate of TL culture supernatant treated with 
deoxyribonuclease. Fractions indicated on the figure (17A) were 
pooled and concentrated on a YM-10 membrane. B. The pool (above) was 
rechromatographed under the same conditions, fractions were pooled as
indicated ( I 1) and assayed for SMAL activity against EL-4 cells.
The numbers are retention time. The salt gradient is described by the 
rising solid line. Peaks are absorption at 280 nm.
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The purification was 5-fold. Although 982 of the protein originally in 
the culture supernatant was removed, 102 of the activity was recovered 
(Table 11). This highly purified SMAL did not bind ethidium bromide 
(Fig. 18, lane 4) and had no peak of absorbance at 258 nm.
Samples of SMAL recovered from the first HPLC purification 
(Fig. 17A) and purified SMAL from the second passage (Fig. 17B) were 
subjected to SDS-FAGE and the gels were stained with silver. SMAL from 
several preparations of the first purification comprised 4-8 components 
(Fig. 19, lane 1) and purified SMAL from several preparations exhibited 
only 3-4 bands (Fig. 19, lane 2). In both samples of SMAL, the most 
heavily stained components were Mr 43,000, and 30,000. The smallest 
component we detected was the Mr 30,000 one. It was not possible to 
purify SMAL to homogeneity or to determine which component was 
responsible for the suppression of the incorporation of K-tdr by EL-4 
cells.
Modes of Action of SMAL. In the experiment reported in Table 12, 
the incorporation of H-tdr by EL-4 cells in the presence of XM-100 
retentate of TL supernatant (SMAL) was inhibited by 872. Since the 
viabilities of these and the control cells was 98%, SMAL appeared to
3
inhibit the incorporation of H-tdr into EL-4 cells by a noncytotoxic 
mechanism. When the numbers of cells in the control and experimental 
cultures were determined, there was no noticeable difference (Table 12).
Distribution of Nuclear DMA in SMAL-treated Cells. EL-4 cells were 
cultured in the presence of XM-100 retentate of TL culture supernatant 
(SMAL) for 24 hr. At the end of this time period, the cells will be
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Figure 18. Absence of DMA In SMAL Purified by HPLC. Samples of 
YM-100 retentate of culture supernatant (lane 1), YM-100 retentate 
treated with DNase (lane 2)» pool 3 from DEAE-cellulose column 
(Fig. 11) (lane 3), and SMAL purified by HPLC (lane 4) were subjected 
to 10Z polyacrylamide gel electrophoresis. The gel was then stained 
with Ethldium bromide and exited with fluorescent light for 
visualization of stained materials (lane 5 is calf thymus DNA).
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Figure 19. SDS-PAGE Analysis of Pooled Fractions from HPLC. A YM-100 
retentate treated with DNase was chromatographed on an anion exchange 
column (QMA-Accell) attached to the HPLC system. Pooled fractions 
from the first and the second purifications by HPLC were analyzed by 
SDS-PAGE followed by staining with silver. Lane 1, pooled fractions 
from the first purification (Fig. 17A). Lane 2, purified SMAL from 
the second purification by HPLC (Fig. 173). The positions of M.V. 
markers are on the left. Lane 3 was loaded with buffers only.
43K
30K
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TABLE 12. Effect of SMAL on the Viability and 
Proliferation of EL-4 Celia
Mean Cell Number x 10~5 ± SD Mean CPM x 10-3 ± SD
Exp. ____________________________ ______________________
No . Control Experimental Control Experimental
I 8,0 ± 0.3 7.9 ± 0.15 (98)a 229 ± 39 31 ± 5 (87)b
IX 8.3 ± 0.58 7.2 ± 0.5 (98) 226 ± 24 105 t 3 (60)
III 8.0 ± 0.35 8.0 ± 0.2 (90) 110 t 8 65 ± 4 (40)
a Percent viability of EL-4 cells aB determined by Trypan Blue dye 
exclusion.
t> 3Percent suppression of H-tdr incorporation.
Cell number was determined by counting the cells in a hemocytometer.
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3
highly suppressed for their Incorporation of H-tdr given as a 2-hr 
pulse. The cells were stained with the Feulgen reagent for DMA and the 
levels of DNA in individual nuclei were determined. There was no 
difference in the distribution of nuclear DNA values between control and 
SMAL-treated cells (Fig. 20). The presence of interclass DNA values 
(Fig. 20B) suggested that DNA synthesis per se was not inhibited by 
SMAL. The data also showed that some cells contained amounts of DNA 
that were roughly even geometric multiples of the 2c and 4c nuclear DNA 
class levels, indicating the presence of cells with hyper tetraplold and 
even octaploid nuclei. Also, metaphase configurations were seen that 
contained 80 or more chromosomes rather than the diploid number of 40-42 
chromosomes expected for EL-4 cells (Gehrlng et al., 1985).
SMAL Inhibits the Uptake of ^H-tdr. Actively growing EL-4 cells 
were cultured for 24 hr in the presence of XM-100 retentate of TL 
supernatant containing 24 units SMAL/ml or in the absence of TL 
supernatant. The cell numbers were determined and found to be identical
for both populations. During this period the cell density increased
5 5 3from 3 x 10 /ml to 8 x 10 /ml. The cultures were pulsed with H-tdr for
2 hr, and after washing the cells the radioactivity in the TCA-soluble
and TCA-precipitable fractions was determined. As depicted in Figure
3
21, the total uptake of H-tdr by SMAL-treated cells was much less (74%)
3
than that of the control cells. The ratio of H-tdr Incorporation into 
TCA-precipitable material to total uptake was, however, similar for the 
control and experimental samples.
3
The extent of suppression of H-tdr incorporation in the presence
3
of increasing concentrations of H-tdr was determined. A double
72
Figure 20. DNA Levels in Nuclei from Control (A) and SMAL-treated (B) 
EL-4 Cells. EL-4 cells were cultured In the presence or absence of 
XM-100 retentate of TL culture supernatant (SMAL) for 24 hr. Cells 
were then fixed with methanol, acetic-acid (3:1 v/v) and microscope 
slides carrying air-dried droplets of fixed cells were stained with 
the Feulgen reagent for DNA. The amount of DNA-Feulgen staining per 
nucleus was measured by using a Vickers M-86 scanning and integrating 
microdensitometer.
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3
Figure 21. Determination of Total Uptake and Incorporated H-tdr by 
SMAL-treated EL-4 Cells. Actively growing EL-4 cells were cultured In 
the presence or absence of SMAL (XM-100 retentate of TL culture 
supernatant) for 24 hr and pulsed with H-tdr for an additional 2 hr. 
The radioactivity incorporated into TCA Insoluble materials and total
3
uptake of H-tdr was determined as described In the Materials and 
Methods.
250
200
E— t Total Uptake 
Ittl Incorporated
Control SMAL
3
The Uptake and Incorporation of H-Thymidine into EL-A Cells 
in the Presence and Absence of SMAL
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reciprocal plot of the data in which 1/[S] is the reciprocal of the
3 3H-tdr concentration and 1/V is the reciprocal of the amount of H-tdr
that was Incorporated (p mol per 2 hr) at Increasing concentrations of 
3
H-tdr up to 6 uM, is shown as Figure 22. There was no change in the
3
extent of suppression of H-tdr incorporation by SMAL, indicating that 
SMAL did not directly compete with the nucleoside.
The Affect of SMAL (XM-100 Retentate of TL Culture Supernatant) on
EL-4 Cells was Reversible. The possibility of adsorption of SMAL to
EL-4 cells was Investigated by measuring the loss of subsequent
suppressive activity in supernatants from cells cultured in known
amounts of SMAL. It was observed that 50% of the original activity was
removed by 6 x 10 cells cultured with either 80 or 700 units/ml of SMAL
for 24 hr (Table 13),
It was then of Interest to determine if the suppression of 
3
incorporation of H-tdr was permanent. Cells were cultured for 22 hr in 
the presence of SMAL, then washed, placed in fresh medium, and assayed
3
for their Incorporation of H-tdr. The results are given in Table 14. 
More than 50% of the original suppression remained when these cells were 
cultured for the last 2 hr in the absence of SMAL. Cells were also 
cultured for 24 hr in the presence of SMAL followed by 24 hr in its 
absence* These cells no longer were suppressed (Table 14).
The reversibility of the effect of SMAL was also demonstrated by a 
different approach. Cells were cultured with SMAL for 24 hr followed by
3
a 1 hr pulse with H-tdr. The cells were then washed and cultured in 
fresh medium. At different time Intervals, aliquots of cell suspension 
were removed, and slides were prepared for autoradiography. As shown in
75
3
Figure 22. Effect of Increasing Concentration of H-tdr on the
Incorporation of this Nucleoside by EL-4 Cells in the Presence or
Absence of SMAL (XM-100 retentate of TL culture supernatant). EL-4
cells were cultured in the presence or absence of XM-100 retentate of TL
culture supernatant for 24 hr and pulsed with different concentrations 
3
of H-tdr. After an additional 2 hr of incubation, the Incorporation of 
3
H-tdr was measured with a liquid scintillation counter. The figure is
3
a double reciprocal plot of data 1/s is pM concentration of H-tdr, 1/v
5
is the amount of thymidine (p mol) Incorporated to 1 x 10 cells in 2 hr 
of pulse.
Thymidine Incorporation t/V (P mol/I x 10 cells)
ro
» \
TABLE 13. Removal of Bioactivity o£ SMAL 
(XM-100 retentate of TL culture supernatant) 
Incubated with EL-A Cells
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SMAL Concentration (unlts/ml)
a  |j
Experiment Control Experimental
No.   (X loss)
I 80 AO (50)
II 700 350 (50)
a SMAL was Incubated In the absence of EL-A cells for 2A hr. 
k SMAL was incubated in the presence of 6 x 10’’ EL-A cells/ml for 2A hr. 
The supernatants then were collected and assayed for SMAL activity as 
described in Materials and Methods.
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TABLE 14. Reversibility of Suppression of 
3
Incorporation of H-tdr by EL-4 Cells Treated with SMAL
_____________ Culture Time_______________ Suppression
SMAL Present3 SMAL Absent b (X + SD)e
(hr) (hr) ___________
24C 0 100
22 2 60 + 19
48d 0 100
24 24 6 + 9
a 54 x 10 EL-4 cells were cultured in 1 ml of XM-100 retentate 
(36-fold).
b Cells were sedimented at 400 x g for 10 mln., washed 3 times with 5 ml
growth medium, and resuspended to 1 ml in growth medium containing 10%
FBS. H-Tdr (4 pCi) was added immediately, and the cells were cultured
for the indicated time, 
c 3H-Tdr (4 pCi) was added after 22 hr, and cultured continued for 
2 more hr.
J Q
K-Tdr (4 pCl) was added after 46 hr, and culture continued for 2 
more hr.
e Data represent three experiments.
Table IS, at zero time, cells treated with SMAL had less than 0.1%
labeled nuclei, whereas 56% of the untreated cells had heavily labeled
nuclei (Fig. 23). After 4 hr of.incubation In the absence of SMAL and 
3
H-tdr, there was a considerable Increase In the percentage of labeled 
nuclei of treated cells (12.4%). It was concluded that In the presence
3
of SMAL the uptake of H-tdr by the cells was Impaired, and the
3 3
Incorporation of H-tdr Into nuclear DNA of the H-tdr which did get
into the cells was inhibited. When SMAL was removed, however, the cells
recovered their ability to incorporate into the nuclei that portion of 
3H-tdr inside them. This was demonstrable by the rise in the number of 
labeled nuclei.
Differential Inhibition of Nucleoside Uptake and Incorporation by 
SMAL-treated EL-4 Cells. The effect of SMAL (XM-100 retentate of TL 
culture supernatant) on the Incorporation of different nucleosides was
investigated. Cells were cultured in the presence or absence of SMAL
3 3 3for 24 hr. They were then pulBed with H-tdr, H-adr or H-udr and
incorporation was determined at different time Intervals (Fig. 24).
3
Labeling of the cells with H-tdr was strongly inhibited (90%) in the
presence of SMAL at the end of 6 hr pulse. The extent of inhibition for
3
the other two nucleosides was much less pronounced, being 30% for H-adr 
and 19% for ^H-udr.
Resistance of SMAL-Treated EL-4 Cells to 5-Fluorodeoxyuridlne. 
5-Fudr is a cytotoxic analog of thymidine. Once inside the cell, it is 
phosphorylated to 5-Fudr-monophosphate by the enzyme thymidine kinase.
It 1b the phosphorylated form of 5-Fudr that is cytotoxic because it
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TABLE 15. Determination of Labeling Indlcles of 
EL-4 Cell Nuclei Treated with SMAL
X of Labeled Nuclei*
SMAL Absent SMAL Present
56.0 0.1
57.0 12.4
14.4 5.6
11.4 6.5
a Slides from population of EL-4 cells grown in the presence or absence 
of SMAL (XM-100 retentate of TL culture supernatant) were prepared for 
autoradiography as described in Materials and Methods. After 24 hr 
exposure the slides were developed and stained with Glemsa. About 1000 
nuclei per preparation were counted to determine the percentage of 
labeled nuclei using an Olympus microscope.
Time Post Pulse 
(hr)
0
4
13
26
80
Figure 23. EL-4 Cell Nuclei Labeled with ^H-tdr. EL-4 cells were
3
cultured in the presence of H-tdr (4 pCi/ml) for 1 hr. They were 
washed, fixed and microscopic slides were prepared for autoradiography 
as described in Materials and Methods. Some labeled and unlabeled 
nuclei are shown with arrows.
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Figure 24. Differential Inhibition of Nucleosides Uptake by SMAL. 
Actively growing EL-4 cells were cultured in the presence or absence
of SMAL (XM-100 retentate of TL culture supernatant) for 24 hr. The
3 3 3cells were then pulsed with H-tdr, H-udr, or H-adr as indicated.
At the end of 6 hr pulse the cells were harvested and the extent of
nucleoside uptake was determined by liuqid scintillation counter as
described in Materials
3
H-udr, Control (solid
and Methods. •--- ^H-tdr, •—  ^H-adr,
lines), SMAL-treated (broken lines).
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binds irreversibly to thymldylate synthetase and by doing so blocks
synthesis of dTmp, In the presence of SMAL the cytotoxic effect of
5-Fudr should be reduced by inhibiting Its entry, preventing its
subsequent phosphorylation or both. Cells were pretreated with SMAL
(XM-100 retentate of TL culture supernatant) for 2k hr and then the
cultures were given different concentrations of 5-Fudr. After 72 hr the
percentages of growth with respect to untreated cells were determined.
As shown in Figure 25, the SMAL-treated cells required more than
26 times 5-Fudr to reduce their growth by 50% (260 nM vs. 10 nM), as
compared to the cellB cultured in the absence of SMAL. These results
3
were consistent with the others which showed uptake of H-Udr was 
reduced in cells suppressed by SMAL, but the huge reduction in 
cytotoxicity of 5-Fudr suggested that phosphorylation of that nucleoside 
analog was inhibited also.
Since these results indicated that the uptake of thymidine was 
reduced in SMAL-treated cells, the possibility that SMAL bound directly 
to the nucleoside transporter site on the cell membrane to block the 
transport of the nucleoside waB investigated. Nitrobenzylthioinosine 
(NBTI) is a potent inhibitor of nucleoside transport. It binds to the 
nucleoside transport sites on the membrane. If SMAL was inhibiting the
3
nucleoside uptake by binding to these sites, then the binding of H-NBTI 
to the cells treated with SMAL should be reduced. Actively growing EL-4 
cells were cultured in the presence or absence of SMAL (XM-100 retentate 
of TL culture supernatant) for 2k hr. H-NBTI w s b  added and its binding 
to the cells was determined. The data (Table 16) showed that there was
3
no reduction in the binding of H-NBTI to the cells in the presence of
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Figure 25. Resistance of SMAL-treated Cells to Cytotoxic Effect of 
5-Fluorodeoxyuridine. EL-4 cells were incubated in the presence ■ • • 
or absence — *—  of SMAL (XM-100 retentate of TL culture supernatant) 
for 24 hr and then received different concentrations of 5-Fudr as 
indicated. After 72 hr, the number of cells were determined with a 
hemocytometer. The percent of growth inhibition was determined by 
comparison to the control cells that did not receive 5-Fudr or SMAL.
Z 
of
 
Gr
ow
th
 
In
hi
bi
ti
on
t o o
50
300100 200
5-Fluorodeoxyuridine (nM)
84
TABLE 16. Binding of 3H-NBTI to 
SMAL-treated EL-4 Cells
Labeled
Substance
3H-tdr
3H-NBTIa
3H-NBTIb
3H-NBTIC
__________Mean cpm ± SD
Control Experimental
470 ± 170 
1,328 ± 40 
1,229 ± 35 
1,381 ± 196
54,188 ± 3,600 
1,254 ± 139 
1,269 ± 54 
1,443 ± 331
&* b* c Represent 3 different experiments.
^ Actively growing EL-4 cells were incubated in the absence (control) or 
presence (experimental) of SMAL (XM-100 retentate of TL culture
3
supernatant) for 24 hr. Cells were then pulsed with 1 pCi of H-NBTI or
3
H-tdr and harvested on GF/C filter paper using a MASH-II multiple 
harvester as described in Materials and Methods.
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3
SMAL despite vast inhibition in the total uptake of H-tdr caused by
SMAL. Therefore, It seems likely that SMAL inhibited the uptake of 
3
H-tdr via a mechanism other than binding to the nucleoside transporter 
where ^H-NBTI binds.
Reduction of Thymidine Kinase Activity in the Cell Extract of EL-4 
Cells Grown in the Presence of HPLC-Purified SMAL. As mentioned above,
3
one effect of SMAL on H-tdr might be a reduction in the activity of
cellular thymidine kinase. To test this possibility, actively growing
EL-4 cells were cultured in the presence or absence of HPLC-purlfled
SMAL for 24 hr. Cell extracts were then prepared and the activity of
thymidine kinase in these extracts was determined. Data representative
of several experiments are shown in Figure 26. The phosphorylation of
thymidine by thymidine kinase in the extract of EL-4 cells grown in the
presence of SMAL (HPLC-purified) was inhibited substantially (Fig. 26A).
The inhibition ranged from 48% to 70% in different experiments. The
observed extent of inhibition of the enzyme, however, was not as marked
3as the suppression of incorporation of H-tdr into intact cells which 
ranged up to 99%. For example, in the experiment for Figure 26 the same 
amount of purified SMAL which led to 70% inhibition of thymidine kinase 
in the treated-cell extract also caused 93% suppression of incoporatlon
3
of H-tdr into the intact cells. This might be due to the fact that in 
intact cells a combination of transport and phosphorylation was being 
measured. It was also found that SMAL did not directly inhibit 
thymidine kinase. When the same amount of purified SMAL was mixed with 
the control cell extract* the activity of the enzyme was unaffected 
(Fig. 26B). Mixing lysates from control and SHAL-treated cells
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Figure 26. Reduced Thymidine Kinase Activity In the Extracts of 
SMAL-treated EL-4 Cells (A) and Lack of Direct Inhibition of Thymidine 
Kinase by SMAL (B). Actively growing EL-4 cells were Incubated in the 
presence or absence of SMAL (HPLC-purified) for 24 hr. Equal number 
of cells were lysed by sonicatlon and the activity of thymidine kinase 
was determined (A). The same amount of purified SMAL was added 
directly to the lysate of untreated cells and the mixture was assayed 
for thymidine kinase activity as described (B).
A B
Eeduced thymidine kinase activity in the extract o£ 
SMAL-treated EL-4 cells (A) and lack of direct Inhibition 
of thymidine kinase by SMAL (B).
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revealed that the reduction In TK activity was not due to the presence 
of a difusable secondary Inhibitor in SMAL-treated cell extract 
(Fig. 27).
3
Effect of SMAL on the Incorporation of H-tdr by Different Cell
3
Lines. The Incorporation of K-tdr by different cell lines in the
presence of SMAL was investigated. SMAL (XM-100 retentate of TL culture
supernatant) was added to the following lines: EL-4 mouse thymoma, F338D
mouse macrophage, CEM-CMg human T cell leukemia, and MDCK dog kidney
epithelial cell line. After 24 hr of incubation they were pulsed with 
3
H-tdr for 2 hr and the amounts of radioactivity taken up by these cells 
was determined. Results are shown in Figure 28. The most sensitive of 
the cell lines to the inhibition by SMAL was CEM-CM3 and the least was
MDCK. At protein concentration of 15 pg per ml, 85!! inhibition of
3
H-tdr incorporation was obtained by CEM-CM^. At the same protein 
concentration only 18!! inhibition was noted for MDCK. Percent 
inhibition for P388D and EL-4 cells were 70 and 40 respectively 
(Fig. 28).
SMAL (HPLC-Purified) at High Concentration was Cytostatic for EL-4
and CEM-CM„ Cells Lines. When EL-4 or CEM-CM„ cells were Incubated in
 .......3---------  3
the presence of different concentrations of SMAL for 48 hr, the
3
incorporation of H-tdr was inhibited at low concentrations of SMAL 
whereas cell growth was not affected. For example, at 20 units of 
SMAL/ml more than 90% inhibition of H-tdr incorporation was noticed 
(Fig. 29), but no considerable inhibition of cell proliferation was 
demonstrable by this concentration of SMAL (Fig. 30). 'At higher
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Figure 27. Thymidine Kinase Activity in Mixtures of Untreated and 
SMAL-treated EL-4 Cell Lysates. EL-4 cells were Incubated in the 
presence or absence of SMAL (HPLC-purified) for 24 hr. Equal numbers 
of cells were lysed by sonlcatlon and lysateB were mixed to different 
proportions as indicated in the figure and assayed for thymidine 
kinase activity as described in Materials and Methods.
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Figure 28. Inhibition of H-tdr Incorporation by Different Cell 
Lines. Actively growing EL-4, CEM-CM^, P3B8D, and MDCK cell lines 
were incubated in 96-well tissue culture plate in the presence or 
absence of SMAL (XM-100 retentate of TL culture supernatants) for 24
3
hr. The cells were pulsed with 1 yCi of H-tdr and the extent of 
3
H-tdr incorporation into TCA-insoluble materials was determined by 
addition of cold TCA to final concentration of 10Z. Cells were 
harvested with a MASH-II multiple harvester and radioactivity was 
determined by liquid scintillation counting, o—  CEM-CM^, ■—  
P388D, •—  EL-4, and*—  MDCK cell line.
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Figure 29. Inhibition of ^H-tdr Uptake by EL-4 and CEM-CM^ Cell Lines 
at Low Doses of SMAL (HPLC-purified). Actively growing EL-4 or 
CEM-CM^ cells were cultured in the presence of different
concentrations of SMAL up to 30 units/ml. The cells were pulsed with
3 3H-tdr for 2 hr and the extent of suppression of H-tdr uptake was
determined as described in Materials and Methods. •—  EL-4 cells;
X  CEM-CM3 cells.
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Figure 30. Inhibition of Cell Growth at Higher Concentrations of SMAL 
(HPLC purified). Actively growing EL-4 or CEM-CM^ cells were cultured 
at initial concentration of 2 x 10  ^cells/ml in the presence of 
different concentration of HPLC-purified SMAL for 72 hr. The number 
of cells were then determined with a hetnocytometer and the extent of 
growth inhibition was determined as described in Materials and 
Methods. •—  EL-4 cells; X  CEM-CM3 cells.
Gr
ow
th
 
In
hi
bi
ti
on
 
at
 
72 
ho
ur
s 
(Z
)
100
50
t o o 200 300
SMAL (Units/ml)
concentrations of SMAL (240 units of SMAL/ml) up to 80% Inhibition of 
cell growth was obtained (Fig. 30). By using the inhibition of 
thymidine Incorporation as an assay for SMAL, this system allowed 
detection of low concentrations of SMAL. Comparison of the tlme-course 
of the impairment in DNA labeling by SMAL and of the inhibition of cell 
proliferation further revealed that the former effect appeared earlier 
after treatment of the target cells with SMAL than did the suppression 
of cell proliferation (Fig. 2 and 31). It is clear that in the presence 
of 240 units of SMAL/ml, the extent of the Inhibition of cell growth 
became maximal within 3 days (Fig. 31), whereas, inhibition of thymidine 
incorporation was demonstrated within 6-8 hr and reached its maximum 
within 24 hr (Fig. 2). As mentioned earlier, the CEM-CM^ cell line 
appeared to be more sensitive to the effects of SMAL than was the EL-4 
cell line.
When EL-4 cells taken from the log phase of cell growth were 
incubated with 300 units of SMAL/ml, they could go through almost one 
round of cell doubling within the first 24 hr of the culture period. 
During the next 48 hr, however, there was no further cell proliferation. 
On the contrary, stationary phase EL-4 cells cultured with the same 
amount of SMAL did not go through any cell division during the 5-day 
incubation time (Fig. 32). This might be due to the fact that 
logarithmically growing EL-4 cells might have produced enough of an 
unknown substance needed for their first round of cell doubling. The 
stationary cells on the other hand presumably were arrested in Gq of the 
cell cycle and did not produce any of this substance. Although this 
substance might be thymidine kinase, EL-4 cells could grow in
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Figure 31. Time Course Effect of SMAL (HPLC-purified) on the Growth 
of EL-4 Cells. Actively growing EL-4 Cells were Cultured in the 
Presence of 240 Units/ml of SMAL up to 3 Days. At 24 hr intervals the 
cell density was determined by counting the cells in a hemocytometer. 
The extent of inhibition of cell growth was determined as described In 
the legends of Figure 30.
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Figure 32, Effect of High Dose of SMAL (HPLC-purified) on the 
Stationery and Log Phase EL-4 Cells, EL-4 cells taken from stationary 
phase or log phase of cell growth (Fig. 1) were cultured in the 
presence of SMAL (300 unlts/ml) for 5 days. At 24-hr intervals, the 
cell density was determined and the extent of inhibition of cell 
growth was determined as described in Figure legend 30, •—  controls,
■■ U SMAL-treated cells, solid lines log phase cells, broken lines 
stationary phase cells.
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nucleoside-free medium and were not dependent on the exogenous 
thymidine. Therefore, this substance might be of a different nature or 
have an unrecognized function.
SMAL (XM-100 Retentate of TL Culture Supernatant) Did Hot Have 
Antiviral Effect. Since some of the properties of SMAL were similar to 
that of interferon it was of Interest to see If SMAL had any antiviral 
activity. To investigate this, human embryonic lung fibroblast cell 
line MRC and human epithelial carcinoma cell line HEP-2 were incubated 
with SMAL for 24 hr. These cultures were then infected with different 
concentrations of clinically Isolated HSV II. The extent of cytopathlc 
effect of HSV II was determined dally for three days using an Inverted 
microscope. As shown in Table 17, the extent of cytopathlc effect of 
HSV II was similar in control and SMAL-treated cells at the range of 
SMAL concentrations of 7.5 to 120 units/ml. It is interesting to note 
that SMAL at concentration of 10 unlts/ml inhibited the Incorporation of 
^H-tdr by MRC and HEP-2 cell lines by 702! and 802! respectively 
(Fig. 33).
These results indicated that SMAL was distinct from interferon 
which was shown to have antiviral activity (Rose et ul., 1986).
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TABLE 17. SMAL did not Inhibit the Cytopathlc Effect of 
Herpes Simplex ViruB II on the Human Embryonic 
Lung Fibroblast MRC Cell Line or HEP-2 Cell Line
Virus8
Dilution Control*1 SMAL Units/ml
120 60 
Cytopathlc Effect
30 15 
at 72 hours
7.5
virus
dilution
c
M - *4 - - -
2 x 10 +4 +4 +4 +4 +4 +4
2 x 103 +4 +4 +4 +4 +4 +4
2 x 10A +3 +3 +3 +3 +3 +3
2 x 105 +2 +2 +2 +2 +2 +2
2 x 107 +2 +2 +2 +2 +2 +2
a Serial dilutions of a stock solution of HSV II were added to MRC or 
HEP-2 cell lines that had previously been treated with SMAL (XM-100 
retentate of TL culture supernatant) for 24 hr. After 72 hr the extent 
of cytopathlc effect of virus were determined as described in Materials 
and Methods.
Control cells did not receive any SMAL. 
c Negative sign means no cytopathlc effect. Positive sign and the 
numbers 1 to 4 denotes increasing extent of cytopathlc effect.
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Figure 33. Inhibition of H-tdr Incorporation by SMAL-Treated MRC and 
HEP-2 Cell Line, Human embryonic lung fibroblast MRC and human 
epithelial carcinoma HEP-2 cell lines were cultured at cell density of 
2 x 10^/ml in 96-well tissue culture plate in the presence or absence 
of SMAL (XM-100 retentate of TL culture supernatant) for 48 hr. The
3
cells were then pulsed with 1 uCi of H-tdr and after 2 hr were 
harvested on a GF/C filter paper with a MASH-II multiple harvester 
after addition of TCA to final concentration of 10%. Percent 
suppression was determined as described in Materials and Methods.
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CHAPTER 4 
Discussion
The fact that immune systems are regulated by a variety of soluble 
suppressor factors is well documented. Some of these are: Inhibitor of 
DNA synthesis (Namba and Waksman, 1975; JegaBOthy and Battles 1979); 
soluble immune response suppressor (Aunne et al., 1983; Tadakuma and 
Pierce, 1978); nonspecific suppressor factor (Aunne and Pierce, 1981b); 
soluble suppressor (Thomas et al., 1975); soluble immune suppressor of T 
cell proliferation (Greene et al., 1981); inhibitor for DNA polymerase 
(Lee and Lucas, 1977); leukocyte inhibitory factor (Rocklin et al., 
1982); lymphotoxin (Granger et al., 1978); and stimulated rat T-cell 
derived inhibitory factor for cellular DNA synthesis (Chiba et al., 
1985a,b).
Data were presented here that showed the supernatant fluid from
cultured human tonsil lymphocytes could suppress the incorporation of 
3
H-tdr into con A-actlvated human PBL, confirming the report of Hodge 
and Inman (1982). The substance responsible for this suppression was 
referred to as SMAL.
The most Important conclusions drawn from this work were: A) SMAL,
3
also, suppressed the Incorporation of H-tdr into mouse EL-4 thymoma 
cell line, human CEM-CM^ T cell leukemia cell line, and mouse P388D 
macrophage cell line; B) proliferation and viability of target cells 
were not affected when the cells were exposed to relatively low 
concentrations of SMAL when they were in early log phase of cell growth; 
C) at relatively high concentrations of SMAL (240 units/ml) target cell
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proliferation was also Impaired; D) the Inhibition of thymidine 
Incorporation began within 6 hr and became extensive within 24 hr; 
however, the inhibition of cell proliferation at high doses of SMAL was 
very slow during the first 24 hr of culture, and peaked within the next 
48 hr; E) the inhibition of thymidine uptake and thymidine incorporation
3
was heavily favored over uridine and adenosine, and the uptake of H-udr
3
and H-adr was not affected to the same extent; F) the reduction in the
3
uptake and incorporation of H-tdr was due in part to both an impairment 
of thymidine transport and a decrease in the activity of thymidine 
kinase, G) SMAL was produced by living TL capable of synthesizing 
protein, and H) SMAL was a protein which could be purified by 
anion-exchange chromatography using HPLC.
The M.W. of SMAL could not be established. When filtered through 
Fractogel TSK 55S, the suppressive activity attributed to SMAL was 
associated with component pools of Mr 630,000, 148,000, and 16,000.
This suggested that SMAL may be a polymer whose smallest M.W. was about 
13,000-16,000. When filtered through XM-300 ultrafilters, however, no 
activity was associated with the retentate. In contrast, all of the 
activity was retained by XM-100 or YM-100 ultrafilters. Alternatively 
the poor resolution of SMAL by gel filtration could be due to a direct 
or indirect binding of SMAL to the gel matrix. The material which was 
applied to the column was TL culture fluid which had been concentrated 
by ultrafiltration on a XM-100 Dlaflo membrane. This solution, which 
was later shown to contain DNA, was not treated with DNase prior to 
application. Several lines of evidence suggested that SMAL was 
associated with DNA, thus the nonspecific interactions of DNA with the
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gel matrix could indirectly result in the retention of SMAL activity on 
the gel. The activity of SMAL was also retained by XM-100 after 
treatment with DNase. These facts indicated the M.W. of SMAL was 
between 100t000 and 300,000 and the Mr 13,000 unit comprised only a 
minor part of the total activity. Under the denaturing conditions of
i
SDS-PAGE, the M.H. of the components of HPLC-purifled SMAL were less 
than 100,000. Constituents of Mr 30,000 and 43,000 stained prominently. 
The 30,000 component was present but was not as noticeable in pool 3 
from the DE-52 column. In both of these preparations, however; a 
Mr 43,000 component was prominent.
The response to con A of PBL drawn from various people, or even 
from the same person on different days, varied. This observation, the 
inconvenience and cost of working with donors, and the difficulty of 
verifying inhibition of proliferation by counting con A-treated PBL led 
to considering the use of a target cell other than human PBL. The EL-4 
cell line was one which was available, and the cells proliferated 
without the necessity of activating them with con A.
The same preparations of SMAL which suppressed incorporation of 
thymidine into PBL also suppressed its incorporation into the xenogeneic 
murine lymphocytes EL-4 cell.line and macrophage P388D cell line as well 
as human T cell leukemia CEM-CM^ cell line. We chose to use EL-4 cells 
as target because of its rapid growth rate and ease of culturing and 
maintenance. SMAL was not cytotoxic to its target cells, and it did not 
inhibit proliferation of them if the cells were exposed to low doses 
(24 units/ml) of SMAL and when they were actively growing. The data 
presented showed that even though the uptake and incorporation of
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exogenous thymidine were inhibited, the rate of DNA synthesis and cell 
proliferation were not affected at low concentrations of the suppressor. 
This effect could be demonstrated within 6 hr of treatment of the EL-4 
cells with SMAL and gradually Increased to its maximum at about 24 hr 
for the population of cells. The use of EL-4 cells allowed one to 
revise the original assay procedure of Hodge and Inman (1982) and 
discontinue the use of PBL. The revised assay was more reliable and 
more convenient than the earlier assay and took considerably less time.
SMAL was produced by living lymphocytes. Neither heat-killed TL 
nor those whose protein synthesis was disrupted by cycloheximlde 
released SMAL into culture medium. When tonsil lymphocytes were 
sonicated before culturing a substantial amount of SMAL-llke activity 
was detected in the sonicates. This indicated that SMAL was present In 
the cells In vivo as expected and was not an artifactual product of In 
vitro culture.
The suppressor was produced In a linear relationship to increasing 
cell density. Most of It was released into the culture supernatants 
during the first 24 hr culture, and progressively less was produced 
during subsequent 24 hr periods. SMAL was accumulated during 
uninterrupted culture time. The TL which were cultured had been 
activated in vivo to various extents as measured by their spontaneous
3
Incorporation of H-tdr. Both the T lymphocyte- and the B 
lymphocyte-enriched fractions were active in this respect. It was also 
revealed that both T and B lymphocyte-enriched fractions produced SMAL 
and that B lymphocyte culture supernatants contained about five tlmeB 
more SMAL than T lymphocyte culture supernatants. The Fercoll density
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gradient: UBed to separate tonsil lymphocytes into B and T lymphocytes 
results only in enriched populations o£ T and B lymphocyte fractions. 
According to Gutierrez et al. (1979), this procedure would yield a B 
cell population consisting of 73% B cells (identified by the presence of 
surface Immunoglobulin G), 11% T cells (identified by formation of 
rosettes with sheep erythrorytes)» and remaining being mainly monocytes. 
The T cell fractions contained 78% T cells, 4% B cells, and Che rest 
were negative for surface immunoglobulin G and rosette formation. 
Assuming that my T and B cell-enriched preparations were similar to 
those of Gutierrez et al (1979), the data suggested that both T and B 
cells synthesized SMAL.
SMAL could be precipitated by ammonium sulfate in a rather broad 
range of 40-80% ammonium sulfate saturation, but the recovery was poor. 
Purification of SMAL by phenyl-sepharose column chromatography was 
unsuccessful and resulted in loss of biological activity.
When concentrated TL culture superantant fluids were 
chromatographed on a DE-52 anion exchange column, SMAL was a component 
of material which adhered rather strongly. Its elution in 0.4 M-0.6 M 
NaCl achieved less than 2-fold purification. It was associated with 
DNA, but pronase destroyed the activity indicating the active moiety was 
the protein. The DNA in the XM-100 or YM-100 retentates of culture 
supernatants was digested by treatment with deoxyribonuclease. The 
retentates then were chromatographed by HPLC. SMAL still adhered 
strongly to the anion-exchanger and was reproduclbly eluted with salt. 
This resulted in 5-fold purification of high specific activity which 
comprised only 3-4 components ranging from approximately
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Mr 30,000-50,000 under denaturing conditions. This purified SMAL did 
not bind EtBr and did not adsorb strongly at 260 nm indicating the 
absence of DNA. There are numerous reports indicating that cultured 
lymphocytes activated by mitogens or antigenB release newly synthesized 
DNA into the culture medium (Sasvari et al., 1984; Banfalvi, 1984; Anker 
et al., 1976; Staub and Antoni, 1978; Adams and Gahan, 1982; Boldt et 
al., 1977; Anker et al., 1975; Rogers, 1976; Rogers and Rucinsky, 1982).
It was demonstrated by Staub and Antoni (1878) that the main part 
of newly synthesized DNA was preferentially released in vitro both by 
non-stlmulated and PHA-stlmulated tonsil lymphocytes. Although a number 
of hypotheses have been put forward to explain the role of excreted DNA, 
its function remains obscure. It was thought originally that released 
DNA might be related to gene amplification (Rogers et al., 1972), but 
other evidence suggested that the released DNA was involved in the 
immune response (Rogers and Kerstin, 1981).
The results presented in this paper also demonstrated that cultured 
human TL synthesised and released DNA into the culture medium, and that 
SMAL was most probably associated and copurified with it on a 
DEAE-cellulose column. Since the bioactlvlty of SMAL was not lost upon 
treatment with deoxyribonuclease, it is plausible that DNA served as a 
carrier for SMAL. When DNase-treated KM-100 retentates were subjected 
to polyacrylamide gel electrophoresis under native conditions, two peaks 
of SMAL activity were recovered from the gels by electroblottlng to 
DEAE-cellulose paper. The bound materials were then eluted by salts. 
SMAL activity was associated with two regions of the gel. The first 
region corresponded to the upper part of the gel indicating that this
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material was large and/or less negatively charged. The second region of 
activity resided at the bottom of the gel, representing a smaller and/or 
highly negatively charged molecule. It has not heen possible to purify 
SMAL to homogeneity or to attribute Its activity to any single band on 
SDS-PAGE due to the lack of sufficient material and loss of bioactlvlty 
of SMAL during the purification.
A major problem inherent in the Isolation and purification of most 
lymphokines has been the lack of substantial quantities of starting 
material for biochemical analysis. It was thought that tonsils would 
provide a large and readily available source of SMAL. However, during 
the course of this work, it became apparent that large volumes of tonsil 
culture supernatants (100 liters) would be needed for purification and 
biochemical characterization of SMAL. Lack of a regular supply of 
tonsils as well as Inconvenience of preparing tonsil lymphocyte cultures 
prompted us to consider establishing a somatic cell hybrid (that can 
produce SMAL) between human tonsil lymphocytes and human T cell leukemia 
cell line CEM-CM^•
Several investigators have produced hybridomas that can potentially 
provide an invaluable resource for a variety of lymphokines (Kouttab et 
al., 1985; Okada et al., 1981; Irigoyen et al., 1981; Theodore et al., 
1986). In the present study, three different fusions were made between 
TL and CEM-CM^ cells but no stable hybrid could be established.
Now, let us discuss some of the effects of SMAL on the EL-4.cells. 
As mentioned earlier, SMAL appeared to have two distinct effects on the 
cells depending on the concentration of SMAL. At low doses, SMAL only 
Impaired the uptake and incorporation of exogenous thymidine without any
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effect on the synthesis of DMA or cell division. At higher
concentrations, however, treatment of EL-4 or CEM-CM^ cell lines with
SMAL resulted in the Inhibition of cell growth. First, the effect of
low doses of SMAL will be described, then its antiproliferative
properties will be discussed.
The effect of SMAL was specific in impairing the uptake and
incorporation of thymidine. In contrast, there was only marginal effect
3 3on the uptake and incorporation of H-udr or H-adr. Membrane transport 
of nucleosides in eukaryotic cells occurs by non-concentratlve 
facilitated diffusion processes; phosphorylation of the substrate traps 
it inside the cells (Oliver and Peterson, 1971; Cass and Paterson, 1972; 
Aronow and Ullman, 1985). The nucleoside transporter in man and pig is 
a polypeptide with M.W. of 45,000-65,000 (Wu et al., 1983). It is known 
that nitrobenzylthioinosine (NBTI) is an irreversible high affinity 
Inhibitor of nucleoside transport (Young et al., 1984). It is also 
known that NBTI binds to the transporter protein as was demonstrated by 
covalent affinity labeling of the protein with photoactivated NBTI 
(Young et al., 1983).
3Although SMAL inhibited the uptake of H-tdr, it apparently did not
3
affect the binding of H-NBTI to the Intact EL-4 cells membrane. Thus, 
it was possible that SMAL was inhibiting the transport of thymidine by 
binding to a site on the plasma membrane of cells distinct from that of 
the NBTI binding site. The possibility of SMAL binding to EL-4 cells 
was demonstrated by the Io s b of activity of SMAL in supernatants of 
culture which were done in the presence of known amounts of the factor. 
Whether this loss of activity was due to the inactivation of SMAL during
the Incubation period with cells or an actual indication of interaction
of SMAL with a receptor was not clear. The fact that SMAL had to be
Incubated with the cells a minimum of 6-8 hr in order to detect a
3
considerable inhibition of H-tdr uptake might indicate a slow 
Interaction and/or entry into the cells. The observed change in 
membrane transport of thymidine may reflect an effect of SMAL on the 
cell surface which could in turn cause an inhibition of H-tdr uptake 
and inhibition of thymidine kinase. In any event, it was clear that the
3
effect of SMAL on the uptake of H-tdr was reversible, suggesting 
perhaps low affinity binding or endocytosls of SMAL. Whatever this 
effect was, it did not Inhibit uridine or adenosine uptake to the same 
extent. These nucleosides may utilize a different system distinct from 
that required for thymidine uptake (Plageman and Erbe, 1972; 1974).
Extract from SMAL-treated cells contained reduced thymidine kinase 
activity as compared to untreated control cells. There are several 
reports correlating thymidine kinase activity with cell growth (Mei-Heui 
and Weber, 1983; Baserga, 1981; Bradshaw, 1983; Cheng et al., 1977; 
Claycomb, 1979; Enggan et al., 1983). However, in spite of the 
decreased thymidine kinase activity in EL-4 cells after 24 hr of 
treatment with SMAL, there was no reduction in the proportion of cells 
in S Phase and no effect on cell proliferation.
Since EL-4 cells propagated in culture medium free of exogenous 
thymidine, SMAL-treated cells could satisfy their growth requirement for 
nucleotides by utilizing their de novo pathway of nucleotide 
biosynthesis. The possibility that nucleosides were derived from serum 
added to the culture was very low because these cells.were able to grow
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in the presence of serum as low as 1%. The obvious question of how SMAL 
from outside the cells could effect thymidine kinase, a cytosolic 
enzyme, remains for further investigations. Coppock and Paradee (1985) 
have shown that the induction of thymidine kinase activity after the 
stimulation of quiescent cells with serum was regulated by a labile 
protein. This protein in turn caused an increase in the level of 
thymidine kinase mRNA in late Gj and early S phase. It Is, therefore, 
possible that SMAL has some effect on this labile protein.
There are also reports showing that thymidine kinase can exist in 
different enzyme .variants in Physarium polycephalum. Some of these 
enzymes can be phosphorylated at the beginning of the S phase (Brobner 
and Loldl, 1984). The phosphorylated thymidine kinase differs from the 
non-phosphorylated form with respect to inhibition by dTTP and Km value 
for thymidine. The phosphorylated forms are less inhibited by dTTP and 
are present in S phase of the cell cycle (Brobner and Loldl, 1984). 
Therefore, it is possible that SMAL is interfering with the 
phosphorylation of thymidine kinase in EL-4 cells and by doing so, 
reducing the enzyme activity.
When SMAL was directly added to the cell extracts which then were 
assayed for thymidine kinase activity, there was no effect on the 
activity of this enzyme. Also, when extracts from SMAL-treated and 
untreated EL-4 cells were mixed, no inhibition of TK activity was 
noticed. These data excluded the possibility of the presence of 
diffusable inhibitors in the extracts of SMAL-treated cells. The data 
were insufficient, however, to conclude whether the reduction in 
thymidine kinase activity was due to the actual inhibition of the enzyme
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or a result of reduction In the amount of enzyme. The effect of
SMAL on the level of transcription or translation of thymidine kinase
remains to be explored.
It was shown by several investigators that interferons (INF) also
have effects on the uptake and phosphorylation of thymidine by human or
mouse lymphoma cell lines (Gewert et al.* 1981; 1983; Lundblad and
Lundgren, 1982; Gewert et al., 1984). These effects were very similar
to that of SMAL on EL-4 cells. Mien SMAL was tested for antiviral
effect, no Inhibition of the cytopathlc effect of herpes simplex virus
on human MRC and HEP-2 cell lines was noted. But, SMAL inhibited the 
3
Incorporation of H-tdr by these cell lines. In addition, the activity 
of SMAL was not destroyed at pH 2, whereas, that of INF was (Valle et 
al., 1975). These observations and the apparently smaller M.W. of INF 
(Ware and Granger, 1979; Rubensteln, 1982; Wlranowska-Stewart, 1981) 
indicated that SMAL and INF probably were not identical molecules.
There were also reports that show D-glucosamlne has inhibitory 
effect on the utilization of exogenous thymidine. Friedman et al.
(1977) reported that In glial tumor cells, the amino sugar caused a 
decreased rate of utilization of exogenous H-tdr for cellular DNA 
synthesis. Tesorier et al. (1984) also observed that D-glucosamine
3
markedly inhibited the incorporation of H-dtr into TCA-precipltable 
materials. This effect was due to the inhibition of thymidine transport 
and thymidine kinase activity in HeLa cells.
Klein et al. (1979) observed that an extract from rat kidney could 
Inhibit thymidine kinase activity and thymidine incorporation in 3T3 
mouse fibroblasts. This inhibitor was partially purified, and its
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activity was detected after treatment with heat, pronase, DNase, and
RNAse. However, It was lost If the pronase or trypsin treated material
was subsequently dialyzed. The inhibitory activity was apparently
related to the carbohydrate moiety of a mucoprotein.
Ashkenazi and Ashkenazi (1976) demonstrated that a DNA extract
prepared from normal human diploid fibroblast cell culture inhibited the
3
uptake and incorporation of H-tdr Into HeLa cells, while the uptake of
3
H-udr was stimulated. This inhibitor was also heat and pronase stable 
and seemed to be related to nucleic acids. Biochemical and biophysical 
properties of SMAL compared to these inhibitors are different. SMAL is 
heat and pronase sensitive, RNase or DNase stable, and has a M.W. of .at 
least 100,000 but smaller than 300,000, and is an acidic protein.
As mentioned earlier, SMAL at higher doses (240 units/ml) was 
cytostatic for its target cells. The inhibition of cell proliferation 
by SMAL was a dose dependent phenomenon. When SMAL was added to EL-4 or 
CEM-CM^ cells at 100 units of SMAL/ml, the growth of CEM-CM^ was 
inhibited by 80%, but more than 240 units of SMAL was required in order 
to inhibit the growth of EL-4 cells by 80%.
CEM-CM^ cells appeared to be more sensitive to the inhibitory
3
effect of SMAL on both the uptake of H-tdr and cell proliferation. It 
was known that CEM-CM^ cell line lacked a functional HGPRT 
(Hypoxantlne-guanine phosphoriboxyl transferase). This enzyme is a key 
enzyme in the salvage pathway of purine nucleosides. Since SMAL 
appeared to inhibit thymidine kinase, a key enzyme in the salvage 
pathway of pyrimidine nucleosides, the higher sensitivity of CEM-CM^ 
might be due to the combined effect of a deficiency in HGPRT and
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SMAL-inhibited thymidine kinase. The Inhibition of cell growth by SMAL 
was a slow process. Within the first 24 hr of Incubation of EL-4 cells 
with SMAL cells only 20-30JE inhibition of cell proliferation was noted. 
Suppression was maximal with 3 days of incubation (80Z). In contrast, 
the cytostatic effect of SMAL was pronounced during the first 24 hr of 
culture time if target cells were taken from the stationary phase of 
growth rather than from the log phase. This might be due to the fact 
that logarithmically growing EL-4 cells have produced enough of an 
unknown substance (i.e. thymidine kinase) needed for their first round 
of cell doubling. The stationary phase cells presumably were docked In 
Gq of cell cycle and did not produce any of this substance.
Whether the inhibition of cell growth was due to the impairment of 
thymidine uptake and thymidine kinase is not clear. As pointed out 
earlier EL-4 cells were routinely cultured In nucleoside-free medium. 
Therefore, it appears that inhibition of cell growth is very unlikely to 
be due to thymidine starvation caused by SMAL. Gewert et al. (1984) 
demonstrated that neither an Intact nucleoside transport system nor 
fully active thymidine kinase were essential for the expression of the 
antiproliferative effect of interferon which inhibits both thymidine 
transport and thymidine kinase. The primary action of SMAL may be at 
DNA level and thymidine metabolism could be altered as a consequence of 
this effect. Alternatively, disruption of the metabolism of thymidine 
may lead to impairment of DNA synthesis.
There were several reports of lymphocytes and tumor cells which 
when cultured, produced supernatants that Inhibited target lymphocyte 
proliferation (Rich et al., 1978; Wolf et al., 1978; Shou et al., 1980;
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Garner et al., 1980; Renk et al., 1980; Lederman et al., 1981; Greene et 
al., 1981; Kramer and Koszlnovskl, 1982; Chiba et al., 1985b). Most of
3
these cited Inhibition of the Incorporation of H-tdr as evidence for 
suppression of proliferation. In the case of the action of SMAL, such a 
conclusion based on similar evidence would have been Incorrect when 
relatively low doses of SMAL were used.
According to current information on SMAL, It had biochemical and 
biological effects characteristics which were both similar end 
dissimilar to those of some of the other factors. Tumor necrosis factor 
(TNF), for example, was cytostatic or cytolytic for several transformed 
cell lines (CarBwell et al., 1975; Ruff and Gifford, 1981a) and 
cytolytic for mouse L-929 fibroblast (Ruff and Gifford, 1981b), but it 
did not affect normal cells. TNF was made by macrophages (M&inel,
1980), but SMAL is produced by macrophage depleted lymphocytes. Under 
nondenaturing conditions, the reported M.W. of TNF derived from human 
monocytes or HL-60 cells varied from 34,000-40,000 (Matthews, 1981; 
Nlssen-Meyer and Hammerstrom, 1982; Aggarwal et al., 1985b) and that 
from immune rabbit serum was 52,000-55,000 (Ruff and Gifford, 1980). 
Purified TNF, however, had a M.W. of 17,000, suggesting native TNF is a 
dimer or trimer.
Lymphotoxin (LT) is a lymphoklne which, like SMAL, is made by 
tonsil cells. When assayed on mouse L-929 fibroblasts, LT is cytolytic 
within 24 hr (Spofford et al., 1974) whereas SMAL is not cytolytic for 
lymphocytes. LT elutes from DEAE-cellulose with 0,1 M NaCl (Aggarwal et 
al., 1984), well below the requirement for elution of SMAL. Under 
nondenaturing conditions, the M.W. of LT derived from a lymphoblastoid
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cell line Is 60*000, but when Its weight Is estimated by SDS-PAGE, It Is
20,000, which closely agrees with the weight calculated from its 
amino acid composition (Aggarwal, 1983a). In contrast, the smallest 
component in purified SMAL preparations had a M.W. of about 30,000.
Another recently recognized tumor cell proliferation Inhibiting 
lymphokine which has some characteristics similar to SMAL is 
leukoregulin. Its M.W. is 135,000 under nondenaturing conditions, and 
32,000 when determined by SDS-PAGE (Ransom et al., 1985; Sayers et al., 
1986). It is made by T cells and null cells from human PBL, a 
B-lymphoblastoid cell line and human B cell mouse myeloma when 
stimulated with PHA. It elutes from DEAE-cellulose in 0,1 M NaCl which 
is less than the concentration required to elute SMAL.
Tonsils are lymphatic organs which are comprised of similar 
percentages of T and B lymphocytes (Sesterhan et al., 1977; Brochler, 
1978) and very small number of macrophages. Their cells produce 
varieties of lymphokines such as lymphotoxln (Granger, 1978), colony 
stimulating factor (Melamed, 1978), and IL-2 (Smith and Ruscetti, 1981). 
Since proliferative response of tonsil lymphocytes in some humans is 
evident by frequent episodes of tissue swelling, it is likely that SMAL 
might be engaged in some immunoregulatory activities.
It will be appropriate to briefly review what is known about the 
mechanism of action of polypeptide growth factors and mitogens and their 
role in stimulating growth. This information might be useful to 
identify possible mechanisms by which SMAL inhibits target cell 
proliferation. The fundamental importance of polypeptide growth factors 
in stimulating growth and maintaining viability in a broad variety of
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cell types has become a generally accepted principal of developmental 
biology. In the past several years, major progress occurred In three 
areas: Identification and Isolation of a large number of polypeptide
growth factors; structural analysis of several of these, including mRNA 
and gene sequences; and receptor characterization for several 
polypeptide growth factors (PGFS).
Among the well characterized PGFS that stimulate the growth of T 
lymphocytes is Interleukin 2, formerly known as T cell growth factor. 
IL-2 is a 15,000 M.H. glycoprotein secreted by T cells in response to 
uitogenic or antigenic stimulation (Morgan et al., 1976). The 
biological role of 1L-2 as an lmmunostlmulant intimately involved in the 
control of T cell proliferation has been firmly established by numerous 
investigations (Lachman and Maizel, 1983).
The availability of large quantities of 1L-2 produced by the human 
T-leukemia cell line Jurkat (Gillis and Watson, 1981) provided the first 
key to the purification and elucidation of the factors structure.
The second breakthrough was the cloning and sequencing of a cDNA 
corresponding to IL-2 mRNA by Tanlguchl et al. (1983) and Shulchlro et 
al. (1983). Furthermore the gene encoding IL-2 has been expressed in 
eukarlotlc and bacterial cells (Rosenberg and Grimm, 1984). The IL-2 
receptor has also been purified and characterized (Kuo and Robb, 1986). 
It was shown by Gaulton and Eardley (1986) that binding of IL-2 to IL-2 
receptor on Con A-stlmulated cells caused rapid phosphorylation of IL-2 
receptor and other membrane proteins. Despite the considerable advances 
noted, little is known regarding the mechanism by which binding of IL-2 
to its receptor induces cellular proliferation.
m
The following eventB happen* in general, after binding of any
mitogen or polypeptide growth factor to its receptor. The receptor
undergoes rapid phosphorylation, redistribution in the plane of the
membrane and endocytosls (James and Bradshaw, 1984). The binding of the
growth factor promotes the generation of early Bignal in the membrane
and cytosol. Within minutes* the mitogenic signal is propagated into
the nucleus. These events eventually lead to synthesis of DNA and cell
division. Some growth factor receptors has been shown to have tyrosine
specific protein kinase activity (Nishimura et al., 1982; Cooper et al.,
1982; Pike et al., 1983). Also the products of retroviral oncogenes
exhibit tyrosine specific protein kinase activity. Therefore, it is
possible that Increased tyrosine phosphorylation Is involved in the
triggering of mitogenesls (Hunter, 1985). After binding, the mitogen or
polypeptide growth factor stimulates a complex set of early eventB in
the membrane, cytosol, and nucleus. These events are: an Increase in 
+ + +
the fluxes of Ha * K * and H across the plasma membrane (Smith and 
Rosengurt, 1978).
In addition to monovalent ion fluxes, there is a marked increase in 
the infflux of Ca++ (Lopez-Rivas et al., 1983). The mobilization of 
Ca may be mediated by inoBitoltrlphosphate (Berridge and Irvine,
1984).
Inosltoltriphosphate is formed as a result of increased hydrolysis 
of phosphatldyllnositol 4,5 blsphosphate in the plasma membrane* and 
this process also generates diacylglycerol. Diacylglycerol is a potent 
activator of purified protein kinase C or protein kinase C in intact 
cells. This enzyme is a major receptor for tumor promoters of the 
phorbol ester family (Nishizuka, 1984).
Activation of this enzyme directly or Indirectly leads to Increased
activity of the Na /H antiport system, which In turn Increases
+ +
Intracellular pH and stimulates the Ha /K pump activity (Vara and 
RoBengurt, 1985). Polypeptide growth factors like platelet-derived 
growth factor (PDGF) also elicit a striking release of arachldonate 
which Is partly derived from diacylglycerol. Arachldonate Is converted 
to many biologically active metabolites Including E-type prostaglandins. 
This in turn leaves the cells and stimulates the synthesis of cAMP via 
Its own receptor. It was shown that cAMP constitutes a growth promoting 
signal for 3T3 mouse fibroblasts (Rosengurt et al., 1981). In addition 
to these events that occur In plasma membranes and cytosols, polypeptide 
growth factors also rapidly and transiently Induce the expression of the 
cellular oncogenes c-fos and c-myc. These oncogenes encode nuclear 
proteins that might have a role In mitogenesis (Rosengurt, 1986).
Any of the events described above that finally lead to DHA 
synthesis and cell division might be a potential target for the 
antiproliferative effect of SMAL. SMAL might prevent the binding of a 
polypeptide growth factor (in the case of EL-4 or CEM-CM^ cells, IL-2) 
to its specific receptor, or SMAL might inhibit the tyrosln specific 
protein kinase activity of the receptor, and/or inhibit protein 
kinase C. The exact mechanism of action of SMAL on the inhibition of 
cell growth and inhibition of uptake and incorporation of exogenous 
thymidine remains open for future investigations. Further information 
on the molecular mechanism of action of SMAL might be useful to 
elucidate some of the unknown events in the signal transduction for 
mitogenesis and cell growth.
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In summary, we have demonstrated In these studies that SMAL Is an
acidic protein made by tonsil lymphocytes which has the ability to
suppress the Incorporation of exogenous thymidine Into con A~stlmulated
normal human PBL, human leukemia T cell line CEM-CM^, normal human
embryonic lung fibroblast MRC, human epidermal carcinoma REP-2, mouse
thymoma EL-4, and mouse macrophage cell line P388D. SMAL is
thermostable at 56°C, but thermolablle at 70°C. It is stable in glycine
pH 2, but destroyed in HC1 and TCA. SMAL is also destroyed by
proteolytic enzymes. Its M.W. under nondenaturing conditions Is in
excess of 100,000, but It may be a polymer whose smallest M.W, may be
30,000. The activity noted in the heterogenous YM-100 or XM-100
retentates of TL culture supernatants is the same as that expressed by
3
purified SMAL, i.e. suppression of Incorporation of H-tdr and 
inhibition of proliferation of target cells.
Future research on SMAL should focus In the following areas:
1. Production of large quantities of SMAL for further purification and 
characterization by either establishing a hybrldoma between tonsil 
lymphocytes and an appropriate partner like CEM-CM^ line, or 
screening a variety tumor cell lines for constitutive release of 
SMAL.
2. Replacement of EL-4 cells by CEM-CM^ cell line in the bloassay for 
SMAL. Because these cells are more sensitive to the effect of 
SMAL.
Production of monoclonal antibody against HPLC-purified SMAL. This 
antibody can be used to prepare Immunoadsorbent affinity columns 
for purification of SMAL, and for development of ELISA or RIA for 
detection of SMAL.
Identification, purification and characterization of receptor(s) 
for SMAL using radiolabeled highly purified SMAL and following the 
fate of SMAL after binding to its receptor(s).
Determination of effect of SMAL on protein phosphorylation, 
specifically tyrosine-specific protein kinase activity and protein 
kinase C activity.
Partial determination of N terminal amino acid sequence of highly 
purified SMAL which may lead to the synthesis of an oligonucleotide 
probe, and utilization of this probe for identification, isolation, 
and cloning of the gene(s) for SMAL.
Information derived from the above experiments might be helpful in 
unraveling the apparently complicated mechanism of control of cell 
proliferation and cell growth.
The antiproliferative effect of SMAL should be investigated in 
vivo, that is to test if SMAL inhibits tumor formation in 
experimental animals like mice. SMAL might have some antitumor 
potential.
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